Blood glucose tracking apparatus

Description

BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention relates to blood glucose monitoring, and particularly to a blood glucose monitor and data management and display device integrated as a synchronous, handheld unit, as an effective and efficient diabetes management tool.

2. Discussion of the Related Art

Blood glucose self-measurements have been conventionally taken by diabetics. The diabetic uses a blood glucose measuring tool. The diabetic typically pricks his or her finger using a lancet. A droplet of exposed blood is applied to a sensor strip which is placed in the glucose measuring tool. A reading appears on a display of the measuring tool indicating the blood glucose level of the diabetic.

Diabetics sometimes use a computer having some form of software that permits the user to track the glucose measurements they have taken. The glucose measurements are typically loaded into the computer manually by the diabetic. Other transfer methods are possible that require steps by the diabetic in order that the information gets entered into the computer, e.g., transferring glucose readings that have been retained in memory of the measuring tool via a cable to the computer. The data may be sent to a health care professional who may also be keeping an eye on the diabetic's status. It is an object of this invention to provide a more efficient and reliable process of taking the measurement, determining the glucose level, entering the glucose level data into a diabetes management program, and managing the diabetes condition using diabetes management software.

In the past, the glucose measurement tool could be carried by the patient for use almost anywhere. However, access to data entry and management using the computer and software have been relegated to a PC setup at a fixed location such as the patient's home, and so these steps had to wait until the diabetic arrived back at his or her home. In the present invention, it is recognized that the development of hand-held devices such as PDAs and mobile phones and PDA/mobile phone combined units could permit diabetics to enter data and use the data management software away from their PCs. It is therefore an object of this invention to provide a system that permits data entry and management by the diabetic away from the diabetic's PC. In addition, it is desired to have a device that permits this mobile data entry and management, and yet permits the user to take off-finger measurements, or using so-called alternate site testing.

Conventional methods have utilized two very separate instruments, the glucose measurement tool and the PC. It is an object of this invention to provide a synchronous tool that performs the conventional functions of both the glucose measurement tool and PC, and perhaps additional features and advantages. It is a further object to synergistically provide this tool, such as by using a same power source and/or a same display for both purposes, i.e., glucose measurement and data management and/or analysis.

SUMMARY OF THE INVENTION

In view of the above, and in particular accordance with the above objects, a measurement module for glucose testing is provided including a glucose testing measurement module housing, a test strip receptacle formed in the housing, and a connector portion formed in the housing and shaped to permit mechanical, removable attachment of the housing to a hand-held processing device, hand-held computer, PDA, mobile phone or wireless processing device. Electronics are provided either in the measurement module or in the hand-held processing device for determining the amount of glucose present in a sample of body fluid, when a test strip is positioned in the receptacle and the fluid is placed on the test strip, and for communicating the glucose amount to the processing device via the connector portion.

The test strip is typically inserted into the test strip receptacle so that the system may calibrate in preparation for application of the body fluid to the strip. Insertion of the strip may further initiate an activation of electrical components that participate in the testing of a body fluid sample. When the system is ready after connecting the measurement module with the hand-held processing device, and after insertion of the strip into the receptacle in the measurement module, and after any calibration or component activation, then the system display preferably indicates that the body fluid is to be now applied to the strip for testing. An alternative system may be or may become available to those skilled in the art wherein the body fluid is applied to the strip, and/or calibration/component activation occur, before strip insertion, and if such system would otherwise include one or more features of preferred embodiments herein, then such systems may also be within the scope of a preferred embodiment.

The housing of the glucose testing measurement module is configured so that a sample of body fluid may be easily applied to the strip when the module is connected to the hand-held processing device and the strip is inserted into the receptacle in the measurement module. The end of the housing from which the strip protrudes is substantially narrowed compared with the end that connects with the hand-held processing device. This narrowed end is preferably a tapered trapezoidal profile, is preferably rounded in two or three directions, protrudes from the connector end defining a shoulder or inset particularly for matching an alternate site body contour and is preferably made of low durometer material, so that the module can rest comfortably and securely on a body location near the test site for easy and precise application of the body fluid to the strip. This configuration of the housing is particularly advantageous when off-finger or alternate site testing is desired such as at an arm or a leg site.

The test strip may be side-filled and may also be tip-filled. Use of a side-filled strip is particularly advantageous for alternate site testing. For example, the module may be rested near the alternate test site (for example a forearm) with a user contacting a rounded shoulder of the housing on the user's skin. The device is then rocked comfortably into a test strip side-fill contact position with the body fluid, due to the ergonometric and/or arthopometric design of the module. For this purpose the module preferably has no square or sharp edges exposed when fitted with the handheld processing device. Even when using a tip-filled strip, exposed edges of the module are preferably rounded for rocking the strip into tip-filled contact with the body fluid, even though the depth of the module is small compared with its width particularly at the wider connection end, and contact with the user may be established perhaps only at a single point on the narrowed end when the body fluid in applied to the strip. The test strip advantageously uses only a relatively small amount of body fluid sample for performing reliable tests, such as less than 1 microliter. Measurements are conducted preferably using a coulometric technique, and alternatively an amperometric, reflectrometic or other technique understood by those skilled in the art, which is significant for alternate site testing wherein typically a lower volume of sample is made available by a same lancing operation at an alternate site than when testing is performed on the finger.

The removable connectability of the measurement module with the hand-held processing device is greatly facilitated by electronics that integrate the two components of this integrated system. An isolation barrier is provided for safe glucose monitoring and/or analysis, even though power is preferably supplied to the module from the hand-held processing device, while also data is transferred between the measurement module and hand-held processing device. The power is preferably transformer-coupled, or alternatively capacitatively-coupled, between the isolated and non-isolated sides of the barrier. Analog front-end signal acquisition circuitry of the measurement module allows signals including data indicative of a blood glucose level or other test of the body fluid to be acquired by the measurement module. Opto-isolators preferably isolate data I/O circuitry and provide a data signal transport route across the barrier to the hand-held processing device so that the data can be analyzed there and/or easily uploaded to a PC by HotSync. By “HotSync”, what is meant is any method of synchronizing data in the handheld with data in a PC, such as by cable, cradle, infrared or radio link. By “analyze”, it is meant that the hand-held processing device can do more than merely display a glucose measurement value. For example, charts, plots and graphs of compiled glucose data can be generated and additional factors such as diet, exercise, insulin regimen, etc., may be used to process and/or display various information relating to a diabetic condition or regimen. Serial to parallel conversion circuitry permits parallel access to a data/address bus of the hand-held processing device to the data transported across the barrier.

In a particular embodiment, a measurement module for glucose testing is further provided including a test strip receptacle in a glucose measurement module, a connector portion formed in the module shaped to permit connection of the module to a hand-held computer by inserting the connector portion of the glucose measurement module into a receptacle defined within the hand-held computer, and electronics for determining the amount of glucose present in a sample of body fluid, when the fluid is placed on a test strip and the test strip is positioned in the receptacle, and for communicating the glucose amount to the hand-held computer via the connector portion.

A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.

A further glucose monitoring apparatus is provided including a measurement module configured to couple with a test sensor and a hand-held processing device electrically and mechanically coupled with and separable from the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.

A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor and a hand-held processing device configured to receive data transmission from the measurement module. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor. The monitoring apparatus includes a single display at the processing device.

A glucose monitoring apparatus is further provided including a measurement module not having a display for displaying results of glucose measurements, the module being configured to couple with a test sensor, and a hand-held processing device configured to receive data transmission from the measurement module. The measurement module and the processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor. The processing device includes a display for displaying the results of said glucose measurements.

A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor and a hand-held processing device configured to receive a data transmission from the measurement module. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement. The processing device is configured for automatically receiving the data transmission after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.

A method of performing a glucose measurement using a measurement module and a hand-held processing device is provided including coupling the processing device electrically and mechanically with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display on the integrated hand-held unit.

A method of performing a glucose measurement using a measurement module and a hand-held processing device is also provided including coupling the processing device with the measurement module to receive a data transmission from the measurement module such that the measurement module and the processing device form a synchronous unit including a single display on the processing device for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a body fluid glucose level from the display on the processing device.

A method of performing a glucose measurement using a measurement module and a hand-held processing device, is further provided including inserting the measurement module into a receptacle defined within the processing device for the processing device to receive a data transmission from the measurement module, such that the measurement module and the processing device form an integrated, hand-held unit for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display on the processing device.

The invention further includes a method of performing a glucose measurement using a measurement module and a hand-held processing device including coupling the processing device with the measurement module to automatically receive a data transmission from the measurement module after a test sensor is inserted into the measurement module, such that the measurement module and the processing device form a synchronous unit for performing and analyzing a glucose measurement, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display.

A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is further geometrically configured to enable off-finger or alternate site application of blood to the test strip.

A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is rounded in three dimensions for providing smooth off-finger or alternate site points of contact with the skin of a person being tested.

A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is rounded in at least two dimensions for providing smooth off-finger or alternate site points of contact with the skin of a person being tested.

A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module includes a telescoping trapezoidal profile for permitting placement of a test strip inserted within the module at an off-finger or alternate site location of a person being tested.

A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module includes an encapsulation port for the test sensor and a PC board including an opto-isolation component. The measurement module extends less than two inches in length and less than one half inch in thickness beyond dimensions of the wireless processing device.

A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device is further provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The processing device is configured to HotSync with a PC. The software program includes instructions for a processor to perform the steps of creating a replica database on the PC of the glucose data stored in a device database on the processing device, and synchronizing the glucose data to a PC database program. The synchronizing step includes reading the glucose data stored in the device database on the processing device, matching the data to corresponding data in the replica database, format converting the data and writing the data to the replica database.

A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test strip and a hand-held processing device is also provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test strip is inserted and body fluid is applied to the test strip. The processing device is configured to HotSync with a PC. The software program includes instructions for a processor to perform the steps of measuring glucose data from the test strip having body fluid applied thereto, automatically downloading the glucose data from the measurement module to the processing device, and downloading the glucose data to a personal computer.

A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The processing device is configured to HotSync with a PC. The method includes creating a replica database on the PC of the glucose data stored in a device database on the processing device, and synchronizing the glucose data to a PC database program. The synchronizing step includes reading the glucose data stored in the device database on the processing device, matching the data to corresponding data in the replica database, format converting the data, and writing the data to the replica database.

A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test strip and a hand-held processing device is also provided. The measurement module and processing device form a detachably integrated, hand-held unit for performing and analyzing a glucose measurement after the test strip is inserted and body fluid is applied to the test strip. The processing device configured to HotSync with a PC. The method includes measuring glucose data from the test strip having body fluid applied thereto, automatically downloading the glucose data from the measurement module to the processing device after measuring said glucose data, and downloading the glucose data to a personal computer.

A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device is further provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The software program includes instructions for a processor to perform the steps of measuring glucose data, providing a sensory output of a glucose level corresponding to the data, and automatically entering the data into a database accessible by a diabetes management software program.

A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device. The measurement module and processing device form a detachably integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The method includes measuring glucose data, providing a sensory output of a glucose level corresponding to the data, and automatically entering the data into a database accessible by a diabetes management software program.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 schematically shows a plan view of an integrated glucose measurement module and hand-held processing device, such as a personal digital assistant or PDA, or mobile phone, integrated phone and PDA, or other wireless device, according to a preferred embodiment.

FIG. 2 shows a block diagram of electrical modules of the integrated glucose measurement module and PDA of FIG. 1.

FIGS. 3
a and 3b schematically illustrate an advantageous electrical isolation barrier feature of an integrated module and PDA according to a preferred embodiment.

FIG. 4 shows an electrical circuitry schematic of a glucose measurement module for integrating with a PDA according to a preferred embodiment.

FIG. 5 shows an electrical circuitry schematic of a PDA for integrating with a glucose measurement module according to a preferred embodiment.

FIG. 6
a schematically shows a bottom plan view of a glucose measurement module for integrating with a PDA according to a preferred embodiment.

FIG. 6
b schematically shows a rear view of the glucose module of FIG. 6a.

FIG. 6
c schematically shows a bottom perspective view of the glucose module of FIG. 6a.

FIG. 6
d schematically shows a top perspective view of the glucose module of FIG. 6a.

FIG. 6
e schematically shows a side view of the glucose module of FIG. 6a.

FIG. 6
f schematically shows a front view of the glucose module of FIG. 6a.

FIG. 6
g schematically shows another side view of the preferred glucose module with preferred dimensions shown in millimeters.

FIG. 6
h schematically shows a top view of the preferred glucose module with preferred dimensions shown in millimeters.

FIG. 6
i schematically shows another rear view of the preferred glucose module with preferred dimensions shown in millimeters.

FIG. 7
a schematically shows a side view of the measurement module of FIG. 6a integrated with a PDA according to a preferred embodiment.

FIG. 7
b schematically shows a plan view of the integrated measurement module and PDA of FIG. 7a.

FIG. 8 illustrates a glucose data handling system software according to a preferred embodiment in block diagram form.

FIG. 9 illustrates a hardware/software block diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.

FIG. 10 shows a data flow diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.

FIG. 11 shows a software data flow diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.

FIG. 12 illustrates a line graph of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment.

FIG. 13 illustrates pie charts of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment.

INCORPORATION BY REFERENCE

What follows is a cite list of references each of which is, in addition to the background, the invention summary, the abstract and the claims, hereby incorporated by reference into the detailed description of the preferred embodiments below, as disclosing alternative embodiments of elements or features of the preferred embodiments not otherwise set forth in detail below. A single one or a combination of two or more of these references may be consulted to obtain a variation of the preferred embodiments described in the detailed description below. Further patent, patent application and non-patent references are cited in the written description and are also incorporated by reference into the preferred embodiment with the same effect as just described with respect to the following references:

U.S. patent application Ser. Nos. 09/413,565, 60/300,011 and 60/280,905, which are assigned to the same assignee as the present application;
Published U.S. application Ser. Nos. 2002029058, 2002025469, 2002008038, 2001054319, and 2001017269, which are also assigned to the same assignee as the present application;
U.S. Pat. Nos. 5,307,263, 5,601,435, 5,899,855, 5,974,124, 6,153,062, 6,330,426, 6,334,778, D427,312, D439,242, D426,638, D424,6966, 338,790, 6,329,161, D450,854, 6,299,757, 6,294,281, 6,281,006, 6,251,260, 6,175,752, 6,120,676, 6,103,033; and GB 1579690, GB 2225637, GB 2194892, GB 2073891, GB 2154003, and GB 2204408; and
EP 0504835, EP 0799896, EP 0800082, EP 0880936, EP 0048090, EP 0078636, EP 0096288, EP 0125139, EP 0136362, EP 0170375, EP 0080304, EP 0184909, EP 0206218, EP 0230472, EP 0241309, EP 0245073, EP 0278647, EP 0286084, EP 0359831, EP 0368209, EP 0390390, EP 0400918, EP 0453283, EP 0470290, EP 0255291, EP 0127958, EP 0781406 and EP 1147739 A2; and
PCT applications No. WO 86/00513, WO 89/02246, WO 90/00367, WO 95/06240, WO 96/07907, WO 96/07908, WO 96/07893, WO 97/20207, WO 97/41421, WO 97/46868, WO 98/09167, WO 98/24366, WO 98/52045, WO 99/05966, WO 99/32883, WO 99/467582, WO 00/13580, WO 00/20626, WO 00/33065, WO 00/78210, WO 01/24038, WO 01/52727, WO 01/33216, WO 01/57238, WO 01/57239, WO 01/67009, WO 85/05119, WO 89/08713, WO 90/05300, WO 91/04704, WO 92/13271, WO 94/20602, WO 94/27140, WO 95/02817, WO 97/00441, WO 97/18464, WO 97/19344, WO 97/42882, WO 97/42883, WO 97/42886, WO 97/42888, WO 97/43962, WO 99/08106, WO 01/88524, WO 01/36430, WO 01/36660, WO 00/78992 and WO 99/30152; and
Schrezenmeir, et al., Computer Assisted Insulin Dosage Adjustment-Perspectives for Diabetes Control, Hormone and metabolic Research, Supplement Series Vol. No. 24, pp. 116-123 Theme Medical Publishers (1990);
A. Michael Albisser, Intelligent Instrumentation in Diabetic Management, Vol. 17, Issue 1, pp. 1-24 (1989);
J. Stuart Soeldner, Treatment of Diabetes Millitus by Devices, the American Journal of Medicine, Vol. 70, 183-194 (January 1981);
New Computer Uses Can Improve Diabetics' Lot, The American Journal of Pharmacy, Vol. 70, pp. 144, 146 (February 1989);
Hiroyuki Norio, Clinical Telecommunication Network System for Home Monitoring, Med. & Biol. Eng. & Comput., 32, 227-230 (March 1994);
A. S. Douglas et al., Hand-Held Glucose Monitor and Recorder, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, New Orleans, 747-748 (Nov. 4-7, 1988);
User's Guide, Accu-Chek Compass Diabetes Care Software, Roche Diagnostics, pp. 1-93 (2000);
Laughton E. Miles, A Portable Microcomputer for Long-Term Physiological Monitoring in the Home and Work Environment, pp. 47-57, Raven Press, eds. Laughton E. Miles and Roger J. Broughton (1990);
P. G. Fabietti et al., Wearable System for Acquisition, Processing and Storage of the Signal from Amperometric Glucose Sensors, International Journal of Artificial Organs, Vol. 14, No. 3, pp. 175-178 (1991);
Heller, A., “Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,” Sensors and Actuators B, 13-14:180-183 (1993);
Heller, A., “Electrical Connection of Enzyme Redox Centers to Electrodes,” J. Phys. Chem, 96(9):3579-3587 (1992); and
Heller, A., “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., 23(5):129-134 (1990).

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

FIG. 1 schematically shows a perspective view of an integrated glucose measurement module 2 and a hand-held processing device 4, such as preferably a personal digital assistant (PDA) 4 or a mobile phone or combined PDA/phone or other wireless device with a processor as may be understood by those skilled in the art. Hereinafter when the term PDA is used it is meant to refer to any of these or other hand-held processing devices, any of which may also be operated using hands-free accessories and/or equipment. The glucose measurement module 2 (hereinafter “module 2”) is shown in FIG. 1 mechanically attached to the PDA 4. The module 2 is in this way physically mounted to and integrated with the PDA 4. The module 2 is also electrically connected to the PDA 4 when mounted into the PDA 4. In addition, the module 2 is software interfaced with the PDA 4 when mounted into the PDA 4. The module 2 shown in FIG. 1 preferably does not have a display, since the display of the PDA 4 may be used for displaying information. The PDA 4 may be replaced by another processing device having a display such as a mobile phone having a connector for attaching the module 2.

The module is shown having a slot 6 for insertion of an in vitro test strip 8. Some details may be found at U.S. patent application Ser. No. 09/413,565, which is assigned to the same assignee as the present application and is hereby incorporated by reference. When the test strip 8 is inserted into the slot 6, preferably blood such as whole blood, plasma and/or serum, and alternatively another body fluid such as interstitial fluid, sweat, urine, tears, saliva, dermal fluid, spinal fluid, etc., is applied to the strip 8 and the module 2 measures the glucose level of the body fluid applied to the strip 8. Hereinafter, whenever blood or body fluid is referred to for being applied to the strip 8, it is meant to include whatever body and/or biological fluid that may be applied to strip 8 for testing. The glucose level data automatically transfers to the PDA 4 (the data transfer mechanism is described in more detail below with reference to FIGS. 2-5), and the glucose level in the blood tested is displayed on the display 10 of the PDA 4, or transmitted through a speaker or otherwise to a user of the device shown in FIG. 1.

The PDA 4 is configured to HotSync with a PC for transmitting data to a PC. The PDA 4 may also transmit data by wireless RF and/or IR connection to a remote or host client or server computer. The PDA 4 also preferably has internet connectability or is otherwise configured for logging into a network for transmitting and receiving data from the network.

FIG. 2 shows a block diagram of electrical modules of the integrated glucose measurement module 2 and PDA 4 of FIG. 1. At the point of the in vitro test strip slot 6 at the top of FIG. 2 is a strip interface 12 including circuitry for connecting to an in vitro test strip for passing a current through blood applied to the strip. Glucose measurement circuitry 14 is shown connected to the strip interface 12 for measuring one or more parameters indicative of a blood glucose level of the blood applied to the strip. An isolated power module 15 provides power to the glucose measurement circuitry 14 and strip interface 12 and ultimately to the test strip.

An isolation barrier 16 is shown for isolating the power at the module from the power at the PDA 4. The isolation barrier 16 is provided to protect the user from having a high current pass through his or her body when the PDA 4 is in a HotSync cradle 18 and thus is connected to AC power. Since an electrically conductive part of the integrated measurement module 2/PDA 4 system (i.e., a strip) contacts the patient, the system may be considered to have a “patient applied part” and would be bound to comply with applicable standards (AAMI ES1, IEC60601-1-2, etc) for isolated patient connections. These standards contain requirements for a maximum amount of current that can flow in either direction between the patient and an AC power line or ground with either the module 2 or the patient in contact with 110% of line voltage.

When the glucose measurement module 2 is inserted into the PDA 4 and the PDA 4 is connected to it's HotSync cradle 18 as shown in FIG. 2, AC ground is connected to the module 2. This connection is made because the ground connection of the HotSync cradle 18 to the PDA 4 is connected to ground at the computer to which the HotSync cradle is connected, which is in turn connected to earth ground at the AC outlet. If AC voltage is applied to the strip connector 12, a large amount of current would flow to AC ground through the module 2, PDA 4, HotSync 18, and/or computer circuitry.

Referring to FIG. 3a, a module 20 connected to PDA circuitry 22 and not having the electrical isolation barrier 16 of FIG. 2 is illustrated. A patient 28 is shown contacting a test strip 30, e.g., for applying blood to the strip or for inserting the strip into the module 20. The patient 28 is also contacting AC power 26 which also powers a computer 24. The computer 24 is shown communicating with the PDA 22 through the HotSync cradle 18. AC ground is shown connected to the computer 24, the Hotsync cradle 18, the PDA circuitry 22, and the module 20. If the user 28 became in contact with the test strip 30 and inadvertently came in contact with any earth referenced potential, large currents would flow through the user 28, and back to earth ground via this path. Conversely, if the module 20 or test strip 30 were to be inadvertently raised to a high potential reference to earth ground, again large currents would flow through the user 28. The risk in each case is electrocution of the user 28 and the standards consider having the user 28 in contact with significant potentials a viable scenario. Should even very small currents flow across the heart, e.g., there is significant risk of causing fibrillation.

In order to prevent this potentially dangerous situation, electrical connections which come into contact with the user 28 at the strip connector 30 are advantageously isolated from earth ground or AC in accord with a preferred embodiment. FIG. 3b illustrates the scenario described above with respect to FIG. 3a except that the module 2 includes the isolation barrier 16 referred to above with reference to FIG. 2. The user 28 who is shown in FIG. 3b in contact with AC power 26 to the computer 24 is also contacting the strip 30 which is connected to the module 2. In contrast with the scenario illustrated by FIG. 3a, the strip 30 is not connected to AC ground, and thus no currents pass through the user 28.

This isolation barrier 16 is preferably created via a physical or otherwise insulating gap in the circuitry on the PC board or the module 20. A preferred dimension of this gap is around 4 mm and is generally dictated by electrical safety standards.

Referring back now to FIG. 2, the glucose measurement circuitry 14 and strip interface 12 are shown on the isolated side of the barrier 16. Power for this isolated circuitry is created by power transfer circuitry 32, which is a transformer coupled, switching power supply according to a preferred embodiment. The transformer 32 bridges the isolation barrier 16 and transfers isolated power 15 to the isolated side of the barrier 16 from the PDA-to-module interface connector 34. For sufficiently low power consumption requirements, a capacitively-coupled supply would be a viable alternative power transfer circuitry 15. Switching control circuitry 36 is on the PDA (ground referenced) side of the isolation barrier 16.

A glucose value is calculated by circuitry 14 on the isolated side of the barrier 16. The glucose value, status, and errors are communicated across the isolation barrier 16 preferably via a bidirectional serial interface 38. Control commands may be preferably received from the PDA 4 via this same interface 38. Serial communication lines of the serial interface 38 bridge the isolation barrier 16 preferably via optoisolators (not shown, but see FIG. 5 and discussion below). Serial information is converted to parallel by serial to parallel conversion circuitry 40 within the module 2 on the PDA side of the barrier 16, so that the module 2 can communicate with the PDA 4. The PDA interface 42 at the module connector 34 is parallel access directly to a PDA data/address bus of PDA circuitry 44. This interface 42 includes control lines as well as power connections.

As an alternative to providing an electrical isolation barrier between module 2 and PDA 4, features can be incorporated into module 2 that prevent it from being used at the same time that PDA 4 is connected to a HotSync cradle or cable, thereby eliminating the risk of passing high levels of electric current through the cradle or cable to or from the patient. This can be accomplished by providing an extended portion of the housing of module 2 that extends down along PDA 4 to interfere with the attachment of a cradle and/or cable to PDA 4 when module 2 is first attached thereto, or prevent the attachment of module 2 when a cradle or cable is already attached to PDA 4.

FIG. 4 shows an electrical circuitry schematic of a glucose measurement module for integrating with a PDA according to a preferred embodiment. The electrical schematic shown in FIG. 4 shows a strip connector 52 for making electrical connection to a strip 8 inserted into the slot 6 of the module 2 of FIG. 1. Analog front end signal acquisition circuitry 54 is shown for acquiring signals indicative of a blood glucose level in blood applied to the strip 8 (FIG. 1). A microprocessor 56 is shown for controlling the module 4. The microprocessor 56 receives isolated power (see element 15 of FIG. 2) as isolated voltage IVcc from an unregulated voltage at point 58 of the schematic of FIG. 4 appearing on the isolated side of the barrier (which is the barrier 16 of FIG. 2), and regulated through regulator 60.

FIG. 5 shows an electrical circuitry schematic of a PDA for integrating with a glucose measurement module according to a preferred embodiment. A connector 62 for mounting the module 2 with the PDA 4 as shown in FIG. 1 is shown next to a memory 64 for storing digital data. At the right in FIG. 5 is a universal asynchronous receiver/transmitter or UART 66. The UART is on the non-isolated side of the barrier 16 of FIG. 2. The UARTs perform the serial to parallel conversion of element 40 of FIG. 2.

Data is transmitted serially from the glucose module 2 to the UART 66 (or converter 40 of the module 2 of FIG. 2) through optoisolator 68. Data is transmitted serially from the UART 66 to the isolated side of the barrier 16 of FIG. 2 through the optoisolator 70. Data may alternatively be transferred across the barrier 16 in parallel. Additional optoisolator components would be used for parallel data transfer compared with serial transfer. Serial transfer is preferred and allows the module 2 to be smaller, more economical to manufacture and more power efficient than if parallel transfer and additional optoisolators are used.

Power is transferred from the PDA 4 through the transformer (corresponding to the power transfer circuitry 32 of FIG. 2). The transformer is preferably a 1:1 transformer, and may be a step-down or step-up transformer of a desired ratio. Through the transformer, power as voltage Vcc is transferred from the non-isolated side of the barrier 16 to the isolated side as isolated power 76. The power may be around 3.3 Volts according to a preferred embodiment.

FIG. 6
a schematically shows a plan view of a glucose measurement module 78 for integrating with a PDA (not shown, but see FIGS. 7a-7b) according to a preferred embodiment. The module 78 includes a mounting portion 80 and a specially shaped extension portion 82. When the module 78 is inserted into a PDA and is mechanically and electrically attached to the PDA and configured to transfer data to/from the PDA, the mounting portion 80 is within the PDA and the extension portion 82 protrudes outside of the PDA.

The module 78 (corresponding to the module 2 of FIG. 2) is about 54 mm wide at the mounting portion 80 which plugs into the PDA 4 and scales down to around 23 mm at the end 86 of the extension portion 82 where the strip 8 of FIG. 1 is inserted. The extension portion 82 itself measures about 54 mm in width at the other end where the mounting portion 80 begins and the extension portion 82 is preferably about 28 mm long from the mounting portion 80 to the strip insertion end 86. The shoulder from which the extension portion 82 narrows most drastically in about 8.5 mm in extent o the approximately 28 mm extent of the extension portion 82. The curvature from the shoulder is about 0.5 rho, which changes direction at a curvature of about 0.5 rho and which changes direction again at a curvature of about 0.6 rho to the strip insertion end 86. As the shoulder flattens out, it makes an angle of about 100° with the elongated direction of the module 78 from the strip end 86, or 80° looking at it from the direction of the mounting portion 80, which angle can be varied somewhat while maintaining the shoulder and also the smoothness of the rounding of the extension portion 82. The extension portion 82 is shown symmetric, but may have an arbitrary curvature on one side the module 78 will be used by resting the extension portion on only the side with rounded features as just described, i.e., it is preferred there are no sharp corners on at least one side of the extension portion 82, and it is more particularly preferred that no sharp corners exist anywhere on the extension portion 82, nor even on the mounting portion 80.

The mounting portion 80 connects electrically and for data transfer to the PDA by preferably a 68 pin electrical connector 84 as shown in FIG. 6b for connecting to a complementary 68 pin male connector of the PDA, wherein the male and female configuration may be reversed or mixed. The thickness of the module 78 is indicated as preferably around 19 mm. FIG. 6b schematically shows a rear view of the glucose module of FIG. 6a. Although not shown, the module 78 attaches mechanically in place in the PDA receptacle by a pair of mechanical latches preferably on opposing sides, e.g., the left and right side in FIG. 6a, of the PDA receptacle.

The extension portion 82 is particularly ergonometrically and/or arthopometrically configured so that a patient may insert a strip into a strip insertion slot (corresponding to slot 6 of FIG. 1) at the end 86 of the extension portion 82, and so that the patient can contact the strip with a drop of blood on the skin of the patient's body. The device is configured so that the patient may choose to use his or her arm, leg or any convenient anatomic location including the finger. This is advantageous because conventional systems often require application of blood to the strip at the finger.

A feature of the shape of the extension portion 82 is its protruding and/or telescoping trapezoidal profile. A utility design is provided at the extension portion 82 of the module 78 that promotes easy and efficient manipulation of the glucose strip on the blood drop whether if be on or off-finger or at an alternate site. The PDA module design incorporates a telescoping trapezoidal profile that allows ease of placement and inhibits the PDA body from encroaching or otherwise interfering with the placement, e.g., at a patient's arm. At the same time, the design is unobtrusive, streamlined and safe.

The telescopic and/or protruding trapezoidal profile of the module includes generous radii on each of the compound edges shown in FIG. 6a. The design allows easy and effective collection of a blood sample from any approved site on the body. The design allows for ease of positioning the module in the proximity of the blood drop and when actually placing the glucose strip on the blood drop. The preferred radii of curvature of each of the three bends on each side of the slot 86 of the extension portion 82 of FIG. 6a are drawn to scale. The curvatures are selected such that the PDA does not interfere with the blood application to the strip, e.g., from a patient's arm, leg or other approved off-finger location, and such that the shoulders of the extension portion 82 of the module 78 may rest gently on the patient's arm while the blood is applied, if the patient chooses, e.g., for support and/or stability. In addition, the design allows for a discreet and unobtrusive profile extending from the PDA. The design is compact and portable and preferably does not include cumbersome and potentially hazardous cables and extra attachments.

The extension 82 is preferably rounded in three dimensions or at least two dimensions, e.g., as illustrated by the various views of the preferred embodiment shown in FIGS. 6c-6f, and as mentioned, preferably has no sharp corners on at least one side which may be rested upon an arm or leg near an alternate site testing location, and for displaying information while testing on each arm for different tests such as on different days, the extension 82 is preferably rounded on both side and is particularly preferably symmetric as shown. FIG. 6c schematically shows a bottom perspective view of the glucose module 78 of FIG. 6a with extension portion 82, mounting portion 80 and pin connector 84. FIG. 6d schematically shows a top perspective view of the glucose module 78 of FIG. 6a with mounting portion 80, extension portion 82 and strip insertion end 86. FIG. 6e schematically shows a side view of the glucose module 78 of FIG. 6a, indicating a total length of about 85 mm, a thickness of about 14 mm at the extension portion 82 and a thickness of about 0.9 mm at the mounting portion 80, wherein the extension portion 82 and mounting portion 80 couple in a staggered fashion with each portion 80 and 82 having an edge which looks out somewhat over the other. FIG. 6f schematically shows a front view of the glucose module of FIG. 6a with the strip insertion portion 86 showing at the end of the extension portion 82. The corners are rounded with radius of curvature about 2.6 mm in the middle of the curve.

FIGS. 6
g, 6h and 6i schematically show another side view, a top view and another rear view of the preferred glucose module with preferred dimensions shown in millimeters. Referring to FIG. 6g, the mounting portion 80 of the module 78 has a thickness of around 14.3 mm, which differs from the 0.9 mm thickness shown at FIG. 6e. The thickness, as well as the width and/or length, of the mounting portion 82 is preferably set to adapt to the dimensions of the receptacle of the hand-held processing device (e.g., PDA, mobile phone, combined PDA/phone, etc.) that the module 78 is to be connected, and these dimensions will vary depending on the device, and so no fixed numeric dimensions are necessarily universally preferred. The rounding of the strip insertion end 86 of the extension portion 82 is shown as having minimum radii of curvature of 9 mm on the bottom side and 2.5 mm on the top side. Referring to FIG. 6h, the rounding from the shoulder of the extension portion has a minimum radius of curvature around 12 mm, while the rounding which is opposite in direction as the rounding from the shoulder has a curvature radius of about 33 mm and that final rounding near the strip insertion end 86 is about 22 mm at minimum. Referring to FIG. 6i, a thickness of around 19.5 mm is shown for the rear view, which shows the pin connector 84, including the thickness of the mounting portion 80 added with the staggered overlooking portion of the extension portion 82, as briefly described above, i.e., so that the staggered overlook portion of the extension portion 82 is about 5 mm.

As shown in FIGS. 6a-6i, the extension portion 82 is rounded away from each side of the slot 86 in two orthogonal directions, and rounds from the slot 86 toward the mounting portion 80, corresponding to a third direction in which the extension portion 82 of the module 78 is rounded. This advantageous design prevents potential hazards such as pinching, lacerations, cuts or skin abrasions, during normal use and handling.

The module 78 serves as a housing for the strip connector, PC board and the opto-isolation components, while not appearing bulky or obtrusive. As mentioned above, the module 78 does not include a display such as a LCD screen because the PDA display may be used as an advantageous PDA accessory for displaying blood glucose levels without delay due to the integrated design of the module 78 with the PDA (see FIG. 1). This contributes to the compactness feature of the design, enabling the module 78 to entend less than two inches beyond the end of the PDA, and as shown in FIG. 6a, less than 1.5 inches and even below 1.2 inches. The module 78 at the extension portion 82 is around or less than 0.25 inches thicker than the PDA. The module 78 weighs less than two ounces and the preferred embodiment shown is around 1.1 ounces, while the design may be configured at less than one ounce. In contrast, if a display such as an LCD were included in the module 78, the module 78 would likely be 50-60% longer, 0.25 inches thicker and be at least two ounces. The preferred module 78 thus does not have a display, and is thus smaller and lighter than if it did have a display, while the integrated module-PDA system has full display capability. Obtaining power to run module 78 from the PDA rather than from an internal power source also contributes to the light, compact arrangement shown.

The module 78 shown and described with respect to FIGS. 6a and 6b including the telescoped, trapezoidal-shaped design has fully-radiused shoulders in an advantageous profile. Some preferred radii and compound angle values are shown in FIG. 6a. From the slot 86, the design rounds toward the PDA at a preferred radius of curvature of 0.6 rho, then rounds in the opposite direction away from the slot 86 at a preferred 0.5 rho and then reverses its curvature again toward the PDA at a preferred 0.5 rho.

The module 78 advantageously mates with a PDA device and forms a single, hand-held unit for glucose measuring and data management. The mechanical design shown in FIGS. 6a-6f allows measurements to be taken that suppress problems that might otherwise present themselves such as interference by the bulky PDA in the blood application process, improper strip placement and positioning, potential for injury, and obtrusiveness. The glucose monitoring strip may be positioned to apply the blood drop, while being attached to the module 78 which is itself mounted into the PDA. The sheer size of the PDA in relation to the module 78 does not inhibit the application process due to the design of the extension portion 82 such that the PDA body does not interfere with or become a hindrance to placement. The shape the profile of the module actually conforms to the shape of a body part such as an arm to which it rested, without presenting itself with an “arm-sliding” problem, as the user positions the module 78 in close proximity to the blood drop. The rounded shape, generous radii and material selection reduce potential hazards to the user, in terms of cuts, lacerations or skin abrasions.

Alternative designs would provide for a more pointed profile to the module 78 to presumably provide easier access to the glucose strip or the module 78 may be alternatively connected through a strip connector and a flexible cable to allow flexibility of placement, independent of the PDA body. These alternative designs are not preferred, however, as the size of the pointed profile may be limited by the size of the strip connector and would likely not allow the user to effectively position the strip due to a lack of plastic real estate. Additionally, a flexible cable, although affording flexibility of placement, would be cumbersome and visibly obtrusive. The preferred design thus has the slightly wider tip such as shown in FIG. 6a and no cumbersome cable is used in the preferred embodiment which includes the module 78 directly mechanically coupled with the PDA.

The module 78 and particularly the extension portion 82 are made of a low durometer material or thermoplastic elastomer facepad detail on both sides of the enclosure, to act as a gripping surface for module insertion and extraction, as well as afford the module a measure of shock absorption. The material may preferably be a PC-ABS alloy or other non-filled plastic resin.

FIG. 7
a schematically shows a side view of the measurement module 78 of FIG. 6a integrated with a PDA 4 according to a preferred embodiment. An indication of an staggered overlook portion of the extension portion 82 being 6.25 mm as opposed to the 5 mm shown about, again indicates that the dimensions of the module 78 can be varied to meet the specifications of the particular hand-held device 4 being used. The mounting portion 80 is shown inserted into the PDA 4 while the extension portion 82 is shown protruding from the PDA 4. FIG. 7b schematically shows a plan view of the integrated measurement module 78, with mounting portion 80 and extension portion 82, and PDA 4 of FIG. 7a. As shown, the extension portion 82, with length of about 28 mm, protrudes from the PDA 4 while the mounting portion 80 of the glucose measurement module 78, with overall length of about 73 mm, is inserted within the receptacle of the PDA 4 (or other hand-held processing device, see above).

FIG. 8 illustrates generally a glucose data handling system software according to a preferred embodiment in block diagram form. FIG. 8 shows a measurement module 90 which receives a glucose strip 92 for measuring a glucose level of blood applied to the strip 92. The measurement module 90 communicates with the PDA which may be running a Palm operating system or other PDA operating system software. The measurement module 90 is preferably configured to turn off nonessential electronics when no measurement is being made. The measurement module preferably includes a microprocessor that controls internal timing, algorithms, result calculation and fault determination, among other responsibilities. The module 90 includes circuitry to connect the serial output of its internal microprocessor to PDA electronics including a mechanism for program initiation and data transfer. The module 90 also preferably provides electronic ESD protection on analog strip connector lines and flash memory for storage of meter firmware and associated user preferences. The module 90 is preferably powered by the PDA, but could alternatively include its own power source, such as button or AAA-size batteries. The module 90 includes electrical isolation between the strip connector and the HotSync port.

The PDA communicates with a PC when the PDA is preferably HotSynced to the PC. The PDA includes RAM as a temporary database for diabetes management application data and/or programs and non-volatile memory for permanent data and/or program storage. The measurement of the glucose level may however be advantageously performed when the PDA is not HotSynced to the PC, and the PDA includes many data processing features itself for managing data without support from the PC. For example, charts and/or graphs may be generated on the PDA display. The PC system includes standard peripheral devices such as a monitor 98, keyboard 100, CD-rom 102 and a printer 104.

FIG. 9 illustrates a hardware/software block diagram of an integrated glucose measurement module 2 and PDA 4 according to a preferred embodiment. The measurement module 2 shown includes a strip connector 52 and analog front end electronics 54, such as those shown in FIG. 4. The measurement module 2 also shows a processor running firmware 110, wherein the processor may be as the processor 56 shown in FIG. 4. The processor is shown having access to non-volatile data storage 112. The isolation barrier 16 is shown wherein the above-mentioned components of the measurement module 2, i.e., the strip connector 52, analog front end electronics 54, processor and firmware 110 and non-volatile data storage 112, are on the isolated side of the barrier 116. PDA meter user interface firmware 114 permits the module 2 to communicate with the PDA 4. A serial to parallel interface, such as that shown in FIG. 2, is also shown in FIG. 9 for converting the serial data transmitted across the barrier 16 using optoisolators 68, 70 such as thos described above with respect to FIG. 5. An interface 116 is shown between the module 2 and PDA 4.

The PDA 4 is shown having a PDA RAM and non-volatile storage 118, a PDA processor 120, a PDA display and touchscreen 122 and a PDA serial interface 124. The PDA is configured to HotSync to a PC system 96, such as that described above with respect to FIG. 8, including a monitor 98, keyboard 100, CD-rom 102 and printer 104. The PC system shown in FIG. 9 also includes a hard drive 126, a CPU 128 and a serial I/O 130 which alternatively may be USB.

The data may be entered on the PDA 4. This data may be HotSynced to the PC 96. The data may also be entered on the PC 96 and reverse HotSynced to the PDA 4. In the former case, e.g., the PC 96 would have an application stored in its memory for accepting this data. This PC application would display and print logbook data in various formats. The PC application would also export data to various data processing applications. The application may use a Microsoft Access Database or MDB format, while the data on the PDA may be stored using the Palm PDB format.

The user is preferably able to reverse HotSync data from the PC in order to restore the data to the state it was when it was last HotSynced. The user might want to do this in the event the database on the PDA becomes corrupted. The PC application and database may store a complete history of data that was entered on the PDA. The PDA user may choose to archive some of the PDA data on the PC.

A conduit program may be used. The program may perform the following steps: (1) create a replica of the data stored on the PDA, on the PC; and (2) synchronize data from the PDA to the database on the PC. The two steps may be performed in two separate conduit programs. Synchronizing the data may include reading data from a PDB file and writing it to the PC database. Microsoft Visual Studio may be used for opening, reading and writing data in the PC database. The data may be read from the PDA, matched to data on the PC, format converted, and written to the PC database. Similarly, data entered or modified on the PC may be matched to data on the PDA. The data on the PDA may be updated to reflect the changes made on the PC.

To match data from the PDA to the PC, unique ID numbers may be used in records on the two systems. These ID numbers may be created on the PDA as logbook records or on the PC as logbook entries there. The uniqueness of the ID numbers may be achieved by pre/post fixing the ID with an origin code identifying PC or PDA, or alternatively perhaps a GUID.

To read data from a PDA file and write it to the PC database, it is recognized herein that data in the PC database may be organized into tables, which may be organized into records, which may be broken down into predefined fields. Similarly, at some level data will be organized into records with a consistent field structure on the PDA.

The conduit program reads the data from the PDA file(s) and writes it out to PC tables. The conduit program also reads data from the PC tables and writes them out to PDA file(s). Various types of data conversion may be used. For example, data residing in fields in the PDA file may be converted from the format it exists in the PDA file to a format compatible with the PC and vice-versa. The logical structure of the records in the two systems may be different. Tables may be created (either in code or in an external file such as a database) which define the mapping of data in fields of one system to data in fields in the other. Data may be stored in temporary table(s) that may later be synchronized with main table(s) that contain a complete logbook history, or the conduit program may write to these tables directly.

FIG. 10 shows a data flow diagram of an integrated glucose measurement module 2 and PDA 4 according to a preferred embodiment. Current is flowed to a strip 8 from the measurement module 2 which, as mentioned, is powered by the PDA 4 as shown and described with respect to FIG. 5. The measurement module 2 includes a setup component 132, which the module 2 communicates to the PDA 4, and a user preferences, calibration code and glucose log component 134. Component 134 serves to convert an electrical reading, such as the current that passes through the blood on the strip 8, to a glucose level, saves a glucose log, saves user preferences, and provides status and error data to the PDA 4. Error data may include glucose errors and charge errors. The PDA 4 is also configured to send user preferences and a calibration code to the measurement module 2 for use or storage by the component 134.

The PDA 4 also receives firmware revision data, measurement state data and temperature data from the measurement module 2. The measurement state and temperature are preferably displayed on a display 10 of the PDA 4 or otherwise provided to a patient by sensory output such as audio or vibration output. The display 10 is preferably also configured to function with touchscreen software and electronics 135. The PDA 4 includes a timer and power module 136, information about which is also displayed. Data regarding the current time is also sent to the module 2 from the timer and power module 136 of the PDA 4.

The PDA advantageously also includes an event database 138 and a user preferences database 140. The event database 138 generally includes information relevant to diabetes management, such as glucose readings. Fields of an event may include time, data, event type. The glucose and error data are stored to the event database 138 after the PDA 4 receives the data from the module 2. The event database includes a logbook which collects glucose, insulin, carbohydrate and exercise data and time. The data in the event database 138 may be graphed in many ways according to helpful default or preprogrammed graphs or according to filtering and preferences inputs from a user. Some exemplary graphs that may be generated on the PDA display 10 from the event database and software loaded on the PDA without the PDA being HotSynced or otherwise connected to a PC or other processing device. In addition, the data including glucose data is automatically sent to the PDA 4 from the module 2 to be stored in the event database 138 where the data can be used to generate graphs that help a user such as a diabetes patient to track glucose and other information. The data measured by the module 2 does not need to be manually entered by the user into a computer before the data can be processed into graphs and the like, or so that the PDA's own software can process or analyze the data to provide useful data analysis to the patient regarding the glucose and other information relating to the condition of the patient. Software on the PDA also preferably includes insulin and carbohydrate tools, and software for communicating with a PC. The user preferences database 140 may store user input such as units of measure, date and time format, an audible or otherwise sensory alert level, the language to be used and other user preferences.

The PC 96 such as that schematically shown at FIGS. 8 and 9 may have additional features. For example, the PC may be configured for viewing and printing the logbook stored on the PDA 4 and transferred to the PDA 4. The PC may be configured to take glucose values and put them into a data management database of its own that may have the same or different capabilities as the event database loaded on the PDA 4. The PC would be helpful for backing-up data and for downloading applications programs to the PDA and also for communicating with other computers over one or more networks. Additional data processing features of the system of the preferred embodiment herein are set forth below with reference to FIG. 11.

FIG. 11 shows a software data flow diagram of an integrated glucose measurement module 2 and PDA 4 according to a preferred embodiment. FIG. 11 shows how four software applications according to a preferred embodiment interact and illustrate functions of these applications and databases that the applications are programmed to utilize. The applications include a meter application 150, a logbook application 152, a diabetes management application 154 and a data management application 156. Each of these applications preferably runs on the PDA which has been described above (e.g., see FIG. 10). These applications may also each run on a PC to which the PDA is configured to communicate. The applications may be downloaded to the PDA or another device from the PC or a server or other digital data storage device such as a CD-rom or magnetic disk.

FIG. 11 also shows a logbook database 158 and a carbohydrate (“carbo”) database 160. The databases 158 and 160 are generally electronic stored records. These may be separate databases or parts of a same database. The logbook and carbo databases may be part of the event database 138 mentioned above with reference to FIG. 10. The logbook database 158 is preferably utilized by each of the applications 150, 152, 154 and 156 mentioned above and shown in FIG. 11, and includes automatic and manual glucose entries, insulin, exercise, meal and other data, and applies user preference filters. The carbo database 160 is preferably utilized by the diabetes management application 154, and includes default carbohydrate data and user entered data. Diabetes management generally refers to activities performed by an individual with diabetes to organize and optimize aspects of life with diabetes such as medication, diet, and exercise that are involved in treating and managing the diabetic condition. The diabetes management application facilitates these activities for the diabetic. The data management application generally provide graphic representations and/or text summaries of data relevant to diabetes management.

The logbook database 158 preferably includes time and date tagged events which are automatically or manually stored such as glucose measurements, manually entered glucose readings, exercise records, insulin injection records, meal time records, state of health records, note records, and medication among others. The user may input entries to the logbook database 158, e.g., that are derived from other glucose meters. Manually entered glucose readings may be flagged as user input rather than meter input. The user may enter other items such as insulin amount, type, and time period, meal times and carbohydrate values, exercise time, type, and degree of exertion (e.g., high, medium, low), state of health, comments and medications. These items may be available to the user from a predefined drop down list that can be edited and added to, or can be manually entered. Data associated with a past event may be entered or modified in the database 158 by the user. Events may be tagged with time periods.

Each application 150-156 is configured to process user inputs including glucose measurements. For example, the meter application is configured to process calibration code input, glucose readings and button presses. The glucose readings are advantageously automatically stored in the logbook database 158 on the PDA according to the programming of the meter application 150. The logbook application 152 is configured to process stored log data and manual entries, and to store and retrieve the log stored log data and manual entries into and from the logbook database 158, respectively. The diabetes management application 154 is configured to process a daily regimen and events such as exercise, meals, insulin dosages and times, etc. and to store and retrieve the daily regimen and events into and from the logbook database 158, respectively. The diabetes management application 154 is also configured to store and retrieve carbo data and manual carbo entries into and from the carbo database 160, respectively. The data management application 156 is configured to process structured data with user filters applied, and to store and retrieve automatic and manual entry information into and from the logbook database, respectively.

The data management application 156 may be configured to allow the user to view data summaries in graphical and text formats. The user may be able to select the length of time to be viewed. The user may also be able to set a default length of time to be viewed from within user preferences. The user may be able to view a complete data set or filter the screen display to show only a selected time period to view. The user may be able to select the event type to be displayed, more than one event type may be selected to be displayed simultaneously. Glucose summary statistics may be displayed by a selected date range and time period. Both selected date range and time period may appear on the display. The summary statistics may include the number of measurements, the highest measurement, the lowest measurement, the average measurement, the standard deviation of the measurements, the percentage of measurements within the target range, the percentage of measurements above the target range, the percentage of measurements below the target range, and insulin and carbohydrate statistics summary. Graphical summaries may also be provided such as line graphs and pie charts (see FIGS. 12-13). The user may be able to select a point on a line graph and see the logbook entry associated with that point.

The diabetes management application 154 may be configured with diabetes management tools such as carbohydrate tables, insulin tables, fast acting carbohydrate list, daily regimen (food and exercise patterns) and target glucose levels. The application 154 may process one or more carbohydrate tables and a food database. The user may be able to choose entries from a database listing carbohydrate values of foods per listed serving size. The user may be able to customize the food database by adding food items to the food database. The user may be able to tag entries as “quick picks”. The diabetes management application 154 may include a lookup table containing the dose of insulin required to lower glucose concentration by a known amount. The user may input insulin dosages based on a health care professional's recommendations.

One or more of the applications 150-156 may be configured to issue “alerts”. These alerts may be warnings directed to the user that are audible, or otherwise sensory such as by vibration, and displayed with graphics and/or text using the display screen on the PDA. Alerts may indicate that a planned activity is due to begin. Event markers may be used to indicate that the user makes an entry into the logbook 158 to designate a specific condition or incident that relates to a specific blood glucose measurement such as meals, time before or after exercise, medication taken, sickness, feeling hypoglycemic, etc. The applications 150-156, and particularly the diabetes management application 154, may be used for self-monitoring of glucose in whole blood, and may be used by people with diabetes and by healthcare professionals as an aid to monitor the effectiveness of diabetes management.

The applications 150-156, and particularly the meter application 150, may be used to provide direction to a user taking a glucose measurement and control data flow to the logbook 158. For example, when the user inserts a test strip into the module, the module is programmed to check the strip and perform a self test. The display then indicates to the user when to apply the blood. The user then applies the blood sample to the strip. The measurement module monitors for fill (the PDA may, e.g., beep on fill) and takes the measurement. The module is programmed to then determine the glucose level and the PDA displays the result. The glucose value is then automatically entered into the electronic logbook, i.e., without user intervention, and the meter waits for further user input. Once the glucose measurement is complete, the meter application 150 may be configured to relinquish control to one or more of the other applications 152-156.

FIG. 12 illustrates a line graph of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment. The data used to generate this graph is stored in the logbook database. The line graph of FIG. 12 shows glucose levels according to the date that the glucose level was taken. As shown, a glucose level that was recorded on November 5 at around 500 mg/dL is labeled as being “Hi” while a glucose level recorded on October 21 at around 20 mg/dL is labeled as “Lo”. A range between around 80 mg/dL and 140 mg/dL is indicated by dashed lines in FIG. 12 suggesting an optimal glucose level range.

FIG. 13 illustrates pie charts of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment. The data used to generate the illustrative graphs of FIG. 13 is stored in the logbook database. All of the pie charts shown in FIG. 13 may be displayed on a display screen 166 of the PDA at the same time, or one or more may be displayed at a single time. The graphs show the percentage of readings that are below, within or above target. For example, chart (a) shows that overall 39% of the time the readings are within target or within the optimal glucose level range of FIG. 12. Charts (b)-(g) show the percentages of readings that are below, within or above target pre-breakfast, pre-lunch, pre-dinner, post-breakfast, post-lunch and post-dinner, respectively. The user can understand his or her glucose level trends from these graphs.

As described above, the advantageous glucose measurement module 2, as schematically shown, e.g., at FIG. 1, including its rounded-contour, tapered-shape narrowed end portion protruding from an inset shoulder of a connector end, and its composition, facilitates off-finger or alternate site testing. The strip 8, and/or any of various embodiments thereof are described at PCT published application No. WO 01/33216 and U.S. patent application Ser. No. 09/434,026, which are assigned to the same assignee as the present application and are hereby incorporated by reference. For example, the invention may use an electrochemical coulometric test strip such as the FreeStyle brand strip sold by TheraSense, Inc. of Alameda, Calif. The FreeStyle strip uses a so-called “side-fill” arrangement.

“Coulometry” is the determination of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte, either directly on the electrode or through one or more electron transfer agents. The charge is determined by measurement of charge passed during partial or nearly complete electrolysis of the analyte or, more often, by multiple measurements during the electrolysis of a decaying current and elapsed time. The decaying current results from the decline in the concentration of the electrolyzed species caused by the electrolysis. “Amperometry”, another method of electrochemically measuring glucose, includes steady-state amperometry, chronoamperometry, and Cottrell-type measurements.

While exemplary drawings and specific embodiments of the present invention have been described and illustrated, it is to be understood that that the scope of the present invention is not to be limited to the particular embodiments discussed. Thus, the embodiments shall be regarded as illustrative rather than restrictive, and it should be understood that variations may be made in those embodiments by workers skilled in the arts without departing from the scope of the present invention as set forth in the claims that follow, and equivalents thereof.

In addition, in the method claims that follow, the steps have been ordered in selected typographical sequences. However, the sequences have been selected and so ordered for typographical convenience and are not intended to imply any particular order for performing the steps, except for those claims wherein a particular ordering of steps is expressly set forth or understood by one of ordinary skill in the art as being necessary.

Claims

1. A diabetes management system, comprising: a device having a housing,an input interface, anda processing circuit coupled to the input interface; anda measurement module electrically coupled to the device, wherein the measurement module includes a measurement module housing,a processor,a non-transitory computer readable medium programmed with instructions that cause the processor to: (a) communicate processor-executable setup software instructions to the processing circuit of the device; and(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,a test strip receptacle formed at a first side of the measurement module housing,electronics for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle, anda connector portion at a second side of the measurement module housing for electrically coupling to the input interface of the device and for transmitting the processor-executable setup instructions and data corresponding to the amount of glucose present in the sample of blood to the device.
2. The diabetes management system of claim 1, wherein a first end of the measurement module housing is narrower than a second end of the measurement module housing.
3. The diabetes management system of claim 1, wherein the measurement module housing has a rounded profile, and wherein the rounded profile of the measurement module housing is curved in two or more directions.
4. The diabetes management system of claim 1, wherein a first end of the measurement module housing has a trapezoidal profile.
5. The diabetes management system of claim 4, wherein the trapezoidal profile results in the first end of the measurement module housing being narrower than a second end of the measurement module housing.
6. The diabetes management system of claim 1, wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.
7. The diabetes management system of claim 1, wherein the system includes only a single display provided in the housing.
8. The diabetes management system of claim 1, wherein the device can process the data received from the measurement module, whether or not the measurement module is integrated with the device.
9. A diabetes management system, comprising: a device having a housing,an input interface, anda processing circuit coupled to the input interface; anda detachable measurement module electrically coupled to the device, wherein the measurement module includes a measurement module housing,a processor,a non-transitory computer readable medium programmed with instructions that cause the processor to: (a) communicate processor-executable setup software instructions to the processing circuit of the device; and(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,a test strip receptacle,electronics for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle, anda connector portion for electrically coupling to the input interface of the device and transmitting the processor-executable setup instructions to the device.
10. The diabetes management system of claim 9, wherein a first end of the measurement module housing is narrower than a second end of the measurement module housing.
11. The diabetes management system of claim 9, wherein the measurement module housing is rounded in two or more directions.
12. The diabetes management system of claim 9, wherein a trapezoidal profile is provided in a first end of the measurement module housing.
13. The diabetes management system of claim 9, wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.
14. The diabetes management system of claim 9, wherein the system includes only a single display provided in the housing.
15. The diabetes management system of claim 9, wherein the device can process the data received from the measurement module, whether or not the measurement module is integrated with device.
16. A measurement module for detachable integration with a device, the measurement module comprising: a housing;a test strip receptacle formed in the housing;electronics disposed within the housing for determining the amount of glucose present in a sample of blood placed on a test strip that is received in the test strip receptacle;a processor,a non-transitory computer readable medium programmed with instructions that cause the processor to:(a) communicate processor-executable setup software instructions to the processing circuit of the device; and(b) after the processor-executable setup software instructions have been communicated from the measurement module to the device and executed by the processing circuit of the device, transmit to the processing circuit of the device information related to diabetes management from the measurement module,a connector portion formed in the housing for insertion into a receptacle formed in the device, wherein the connector portion provides electrical coupling to the device to transmit the processor-executable setup instructions and data corresponding to the amount of glucose present in the sample of blood.
17. The measurement module of claim 16, wherein the test strip receptacle is provided at a first end of the housing.
18. The measurement module of claim 16, wherein the housing is rounded in two or more directions.
19. The diabetes management system of claim 16, wherein insertion of the test strip in the test strip receptacle initiates an activation of the electronics for determining the amount of glucose present in the sample of blood.
20. The diabetes management system of claim 1, wherein the measurement module is powered by the device.
21. The diabetes management system of claim 9, wherein the measurement module is powered by the device.

Parent Case Info

This application is a continuation patent application of U.S. patent application no. 11/160,407, filed Jun. 22, 2005; which is a continuation patent application of U.S. patent application Ser. No. 10/112,671, filed Mar. 29, 2002, which claims the benefit of priority to U.S. provisional patent applications No. 60/300,011, filed Jun. 20, 2001, and 60/280,905, filed Apr. 2, 2001, which are assigned to the same assignee as the present application and are hereby incorporated by reference.

US Referenced Citations (1736)

Number	Name	Date	Kind
2402306	Turkel	Jun 1946	A
3132123	Harris, Jr. et al.	May 1964	A
3219533	Mullins	Nov 1965	A
3260656	Ross, Jr.	Jul 1966	A
3282875	Connolly et al.	Nov 1966	A
3304413	Lehmann et al.	Feb 1967	A
3310606	Fritz	Mar 1967	A
3397191	Beckerbauer	Aug 1968	A
3635926	Gresham et al.	Jan 1972	A
3651318	Czekajewski	Mar 1972	A
3653841	Klein	Apr 1972	A
3698386	Fried	Oct 1972	A
3719564	Lilly, Jr. et al.	Mar 1973	A
3768014	Smith et al.	Oct 1973	A
3775182	Patton et al.	Nov 1973	A
3776832	Oswin et al.	Dec 1973	A
3785939	Hsu	Jan 1974	A
3837339	Aisenberg et al.	Sep 1974	A
3851018	Kelly	Nov 1974	A
3910257	Fletcher et al.	Oct 1975	A
3919051	Koch et al.	Nov 1975	A
3926760	Allen et al.	Dec 1975	A
3929971	Roy	Dec 1975	A
3930889	Ruggiero et al.	Jan 1976	A
3933593	Sternberg	Jan 1976	A
3964974	Banauch et al.	Jun 1976	A
3966580	Janata et al.	Jun 1976	A
3972320	Kalman	Aug 1976	A
3979274	Newman	Sep 1976	A
4008717	Kowarski	Feb 1977	A
4016866	Lawton	Apr 1977	A
4024312	Korpman	May 1977	A
4032729	Koistinen	Jun 1977	A
4036749	Anderson	Jul 1977	A
4040908	Clark, Jr.	Aug 1977	A
4055175	Clemens et al.	Oct 1977	A
4059406	Fleet	Nov 1977	A
4059708	Heiss, Jr. et al.	Nov 1977	A
4068536	Stackhouse	Jan 1978	A
4073713	Newman	Feb 1978	A
4076596	Connery et al.	Feb 1978	A
4076656	White et al.	Feb 1978	A
4098574	Dappen	Jul 1978	A
4100048	Pompei et al.	Jul 1978	A
4101814	Haferl	Jul 1978	A
4129128	McFarlane	Dec 1978	A
4151845	Clemens	May 1979	A
4154231	Russell	May 1979	A
4168205	Danniger et al.	Sep 1979	A
4172770	Semersky et al.	Oct 1979	A
4178916	McNamara	Dec 1979	A
4193982	Avrameas et al.	Mar 1980	A
4197840	Beck et al.	Apr 1980	A
4206755	Klein	Jun 1980	A
4215703	Wilson	Aug 1980	A
4224125	Nakamura et al.	Sep 1980	A
4240438	Updike et al.	Dec 1980	A
4240889	Yoda et al.	Dec 1980	A
4241438	Kern	Dec 1980	A
4245634	Albisser et al.	Jan 1981	A
4247297	Berti et al.	Jan 1981	A
4255500	Hooke	Mar 1981	A
4259540	Sabia	Mar 1981	A
4271449	Grogan	Jun 1981	A
4275225	Krespan	Jun 1981	A
4318784	Higgins et al.	Mar 1982	A
4324257	Albarda et al.	Apr 1982	A
4327725	Cortese et al.	May 1982	A
4331869	Rollo	May 1982	A
4335255	Krespan	Jun 1982	A
4340458	Lerner et al.	Jul 1982	A
4344438	Schultz	Aug 1982	A
4352960	Dormer et al.	Oct 1982	A
4353888	Sefton	Oct 1982	A
4356074	Johnson	Oct 1982	A
4357282	Anderson et al.	Nov 1982	A
4365637	Johnson	Dec 1982	A
4366033	Richter et al.	Dec 1982	A
4374013	Enfors	Feb 1983	A
4375399	Havas et al.	Mar 1983	A
4384586	Christiansen	May 1983	A
4388166	Suzuki et al.	Jun 1983	A
4390621	Bauer	Jun 1983	A
4392933	Nakamura et al.	Jul 1983	A
4401122	Clark, Jr.	Aug 1983	A
4404066	Johnson	Sep 1983	A
4407288	Langer et al.	Oct 1983	A
4407959	Tsuji et al.	Oct 1983	A
4415666	D'Orazio et al.	Nov 1983	A
4417588	Houghton et al.	Nov 1983	A
4418148	Oberhardt	Nov 1983	A
4420564	Tsuji et al.	Dec 1983	A
4425920	Bourland et al.	Jan 1984	A
4427004	Miller et al.	Jan 1984	A
4427770	Chen et al.	Jan 1984	A
4431004	Bessman et al.	Feb 1984	A
4431507	Nankai et al.	Feb 1984	A
4436094	Cerami	Mar 1984	A
4440175	Wilkins	Apr 1984	A
4443218	DeCant, Jr. et al.	Apr 1984	A
4444892	Malmros	Apr 1984	A
4450842	Zick et al.	May 1984	A
4458686	Clark, Jr.	Jul 1984	A
4461691	Frank	Jul 1984	A
4467811	Clark, Jr.	Aug 1984	A
4469110	Slama	Sep 1984	A
4476003	Frank et al.	Oct 1984	A
4477314	Richter et al.	Oct 1984	A
4478976	Goertz et al.	Oct 1984	A
4483924	Tsuji et al.	Nov 1984	A
4484987	Gough	Nov 1984	A
4494950	Fischell	Jan 1985	A
4499249	Nakagawa et al.	Feb 1985	A
4506680	Stokes	Mar 1985	A
4512348	Uchigaki et al.	Apr 1985	A
4522690	Venkatsetty	Jun 1985	A
4524114	Samuels et al.	Jun 1985	A
4526661	Steckhan et al.	Jul 1985	A
4526948	Resnick	Jul 1985	A
4527240	Kvitash	Jul 1985	A
4530696	Bisera et al.	Jul 1985	A
4534356	Papadakis	Aug 1985	A
4538616	Rogoff	Sep 1985	A
4543955	Schroeppel	Oct 1985	A
4544869	Pittaway	Oct 1985	A
4545382	Higgins et al.	Oct 1985	A
4552840	Riffer	Nov 1985	A
4560534	Kung et al.	Dec 1985	A
4561443	Hogrefe et al.	Dec 1985	A
4569589	Neufeld	Feb 1986	A
4571292	Liu et al.	Feb 1986	A
4573994	Fischell et al.	Mar 1986	A
4577642	Stokes	Mar 1986	A
4581336	Malloy et al.	Apr 1986	A
4595011	Phillips	Jun 1986	A
4595479	Kimura et al.	Jun 1986	A
4614760	Homan et al.	Sep 1986	A
4619754	Niki et al.	Oct 1986	A
4619793	Lee	Oct 1986	A
4627445	Garcia et al.	Dec 1986	A
4627908	Miller	Dec 1986	A
4633878	Bombardien	Jan 1987	A
4633881	Moore et al.	Jan 1987	A
4637403	Garcia et al.	Jan 1987	A
RE32361	Duggan	Feb 1987	E
4648408	Hutcheson et al.	Mar 1987	A
4650547	Gough	Mar 1987	A
4653513	Dombrowski	Mar 1987	A
4654197	Lilja et al.	Mar 1987	A
4655880	Liu	Apr 1987	A
4655885	Hill et al.	Apr 1987	A
4658463	Sugita et al.	Apr 1987	A
4663824	Kenmochi	May 1987	A
4671288	Gough	Jun 1987	A
4674652	Aten et al.	Jun 1987	A
4679562	Luksha	Jul 1987	A
4680268	Clark, Jr.	Jul 1987	A
4681111	Silvian	Jul 1987	A
4682602	Prohaska	Jul 1987	A
4684537	Graetzel et al.	Aug 1987	A
4685463	Williams	Aug 1987	A
4686624	Blum et al.	Aug 1987	A
4695011	Komatsubara et al.	Sep 1987	A
4698582	Braun et al.	Oct 1987	A
4703756	Gough et al.	Nov 1987	A
4711245	Higgins et al.	Dec 1987	A
4711251	Stokes	Dec 1987	A
4714462	DiDomenico	Dec 1987	A
4717673	Wrighton et al.	Jan 1988	A
4718893	Dorman	Jan 1988	A
4721601	Wrighton et al.	Jan 1988	A
4721677	Clark, Jr.	Jan 1988	A
4726378	Kaplan	Feb 1988	A
4726716	McGuire	Feb 1988	A
4731051	Fischell	Mar 1988	A
4731726	Allen, III	Mar 1988	A
4747828	Tseo	May 1988	A
4749985	Corsberg	Jun 1988	A
4750496	Reinhardt	Jun 1988	A
4753652	Langer et al.	Jun 1988	A
4757022	Shults et al.	Jul 1988	A
4758323	Davis et al.	Jul 1988	A
4759371	Franetzki	Jul 1988	A
4759828	Young et al.	Jul 1988	A
4764416	Ueyama et al.	Aug 1988	A
4776944	Janata et al.	Oct 1988	A
4777953	Ash et al.	Oct 1988	A
4779618	Mund et al.	Oct 1988	A
4781798	Gough	Nov 1988	A
4784736	Lonsdale et al.	Nov 1988	A
4787398	Garcia et al.	Nov 1988	A
4795707	Niiyama et al.	Jan 1989	A
4796634	Huntsman et al.	Jan 1989	A
4803243	Fujimoto et al.	Feb 1989	A
4803625	Fu et al.	Feb 1989	A
4803726	Levine et al.	Feb 1989	A
4805624	Yao et al.	Feb 1989	A
4810470	Burkhardt et al.	Mar 1989	A
4813424	Wilkins	Mar 1989	A
4815469	Cohen et al.	Mar 1989	A
4820399	Senda et al.	Apr 1989	A
4822337	Newhouse et al.	Apr 1989	A
4830959	McNeil et al.	May 1989	A
4832797	Vadgama et al.	May 1989	A
4835372	Gombrich et al.	May 1989	A
RE32947	Dormer et al.	Jun 1989	E
4837049	Byers et al.	Jun 1989	A
4838887	Idriss	Jun 1989	A
4840893	Hill et al.	Jun 1989	A
RE32974	Porat et al.	Jul 1989	E
4844076	Lesho et al.	Jul 1989	A
4845035	Fanta et al.	Jul 1989	A
4848351	Finch	Jul 1989	A
4849458	Reed et al.	Jul 1989	A
4854322	Ash et al.	Aug 1989	A
4856340	Garrison	Aug 1989	A
4857713	Brown	Aug 1989	A
4858617	Sanders	Aug 1989	A
4870561	Love et al.	Sep 1989	A
4871351	Feingold	Oct 1989	A
4871440	Nagata et al.	Oct 1989	A
4874499	Smith et al.	Oct 1989	A
4874500	Madou et al.	Oct 1989	A
4889744	Quaid	Dec 1989	A
4890620	Gough	Jan 1990	A
4890621	Hakky	Jan 1990	A
4894137	Takizawa et al.	Jan 1990	A
4896142	Aycox et al.	Jan 1990	A
4897162	Lewandowski et al.	Jan 1990	A
4897173	Nankai et al.	Jan 1990	A
4897457	Nakamura et al.	Jan 1990	A
4899839	Dessertine et al.	Feb 1990	A
4909908	Ross et al.	Mar 1990	A
4911794	Parce et al.	Mar 1990	A
4917800	Lonsdale et al.	Apr 1990	A
4919141	Zier et al.	Apr 1990	A
4919767	Vadgama et al.	Apr 1990	A
4920969	Suzuki	May 1990	A
4920977	Haynes	May 1990	A
4923586	Katayama et al.	May 1990	A
4925268	Iyer et al.	May 1990	A
4927407	Dorman	May 1990	A
4927516	Yamaguchi et al.	May 1990	A
4931795	Gord	Jun 1990	A
4934369	Maxwell	Jun 1990	A
4935105	Churchouse	Jun 1990	A
4935345	Guilbeau et al.	Jun 1990	A
4936956	Wrighton	Jun 1990	A
4938860	Wogoman	Jul 1990	A
4942127	Wada et al.	Jul 1990	A
4944299	Silvian	Jul 1990	A
4945045	Forrest et al.	Jul 1990	A
4950378	Nagata	Aug 1990	A
4953552	DeMarzo	Sep 1990	A
4954129	Giuliani et al.	Sep 1990	A
4955861	Enegren et al.	Sep 1990	A
4957115	Selker	Sep 1990	A
4958632	Duggan	Sep 1990	A
4963595	Ward et al.	Oct 1990	A
4968400	Shimomura et al.	Nov 1990	A
4969468	Byers et al.	Nov 1990	A
4970145	Bennetto et al.	Nov 1990	A
4974929	Curry	Dec 1990	A
4979509	Hakky	Dec 1990	A
4984929	Rock et al.	Jan 1991	A
4986271	Wilkins	Jan 1991	A
4986671	Sun et al.	Jan 1991	A
4990845	Gord	Feb 1991	A
4991582	Byers et al.	Feb 1991	A
4994068	Hufnagie	Feb 1991	A
4994167	Shults et al.	Feb 1991	A
4995402	Smith et al.	Feb 1991	A
5001054	Wagner	Mar 1991	A
5002054	Ash et al.	Mar 1991	A
5002572	Picha	Mar 1991	A
5007427	Suzuki et al.	Apr 1991	A
5007929	Quaid	Apr 1991	A
5016172	Dessertine	May 1991	A
5016201	Bryan et al.	May 1991	A
5016631	Hogrefe et al.	May 1991	A
5019974	Beckers	May 1991	A
5030333	Clark, Jr.	Jul 1991	A
5034112	Murase et al.	Jul 1991	A
5034192	Wrighton et al.	Jul 1991	A
5035860	Kleingeld et al.	Jul 1991	A
5036860	Leigh et al.	Aug 1991	A
5036861	Sembrowich et al.	Aug 1991	A
5037527	Hayashi et al.	Aug 1991	A
5049487	Phillips et al.	Sep 1991	A
5050612	Matsumura	Sep 1991	A
5055171	Peck	Oct 1991	A
5058592	Whisler	Oct 1991	A
5059654	Hou et al.	Oct 1991	A
5063081	Cozzette et al.	Nov 1991	A
5067491	Taylor et al.	Nov 1991	A
5068536	Rosenthal	Nov 1991	A
5070535	Hochmair et al.	Dec 1991	A
5073500	Saito et al.	Dec 1991	A
5074977	Cheung et al.	Dec 1991	A
5077476	Rosenthal	Dec 1991	A
5078854	Burgess et al.	Jan 1992	A
5082550	Rishpon et al.	Jan 1992	A
5082786	Nakamoto	Jan 1992	A
5084828	Kaufman et al.	Jan 1992	A
5088981	Howson et al.	Feb 1992	A
5089112	Skotheim et al.	Feb 1992	A
5094951	Rosenberg	Mar 1992	A
5095904	Seligman et al.	Mar 1992	A
5096560	Takai et al.	Mar 1992	A
5096836	Macho et al.	Mar 1992	A
5097834	Skrabal	Mar 1992	A
5101814	Palti	Apr 1992	A
5106365	Hernandez	Apr 1992	A
5108564	Szuminsky et al.	Apr 1992	A
5109850	Blanco et al.	May 1992	A
5111539	Hiruta et al.	May 1992	A
5111818	Suzuji et al.	May 1992	A
5114678	Crawford et al.	May 1992	A
5120420	Nankai et al.	Jun 1992	A
5120421	Glass et al.	Jun 1992	A
5126034	Carter et al.	Jun 1992	A
5126247	Palmer et al.	Jun 1992	A
5130009	Marsoner et al.	Jul 1992	A
5131441	Simpson et al.	Jul 1992	A
5133856	Yamaguchi et al.	Jul 1992	A
5134391	Okada	Jul 1992	A
5135003	Souma	Aug 1992	A
5139023	Stanley et al.	Aug 1992	A
5140393	Hijikihigawa et al.	Aug 1992	A
5140985	Schroeder et al.	Aug 1992	A
5141868	Shanks et al.	Aug 1992	A
5147725	Pinchuk	Sep 1992	A
5153827	Coutre et al.	Oct 1992	A
5161532	Joseph	Nov 1992	A
5165407	Wilson et al.	Nov 1992	A
5168046	Hamamoto et al.	Dec 1992	A
5171689	Kawaguri et al.	Dec 1992	A
5174291	Schoonen et al.	Dec 1992	A
5176644	Srisathapat et al.	Jan 1993	A
5176662	Bartholomew et al.	Jan 1993	A
5182707	Cooper et al.	Jan 1993	A
5184359	Tsukamura et al.	Feb 1993	A
5185256	Nankai et al.	Feb 1993	A
5190041	Palti	Mar 1993	A
5192415	Yoshioka et al.	Mar 1993	A
5192416	Wang et al.	Mar 1993	A
5193539	Schulman et al.	Mar 1993	A
5193540	Schulman et al.	Mar 1993	A
5197322	Indravudh	Mar 1993	A
5198367	Aizawa et al.	Mar 1993	A
5198771	Fidler et al.	Mar 1993	A
5200051	Cozzette et al.	Apr 1993	A
5202261	Musho et al.	Apr 1993	A
5205920	Oyama et al.	Apr 1993	A
5206145	Cattell	Apr 1993	A
5208154	Weaver et al.	May 1993	A
5209229	Gilli	May 1993	A
5215887	Saito	Jun 1993	A
5216597	Beckers	Jun 1993	A
5217442	Davis	Jun 1993	A
5217595	Smith et al.	Jun 1993	A
5227042	Zawodzinski et al.	Jul 1993	A
5229282	Yoshioka et al.	Jul 1993	A
5232668	Grant et al.	Aug 1993	A
5235003	Ward et al.	Aug 1993	A
5242848	Yeh	Sep 1993	A
5243983	Tarr et al.	Sep 1993	A
5246867	Lakowicz et al.	Sep 1993	A
5249576	Goldberger et al.	Oct 1993	A
5250439	Musho et al.	Oct 1993	A
5251126	Kahn et al.	Oct 1993	A
5257971	Lord et al.	Nov 1993	A
5257980	Van Antwerp et al.	Nov 1993	A
5259769	Cruise et al.	Nov 1993	A
5261401	Baker et al.	Nov 1993	A
5262035	Gregg et al.	Nov 1993	A
5262305	Heller et al.	Nov 1993	A
5264103	Yoshioka et al.	Nov 1993	A
5264104	Gregg et al.	Nov 1993	A
5264106	McAleer et al.	Nov 1993	A
5265888	Yamamoto et al.	Nov 1993	A
5266179	Nankai et al.	Nov 1993	A
5269212	Peters et al.	Dec 1993	A
5271736	Picha	Dec 1993	A
5271815	Wong	Dec 1993	A
5272060	Hamamoto et al.	Dec 1993	A
5275159	Griebel	Jan 1994	A
5276610	Maeda et al.	Jan 1994	A
5278079	Gubinski et al.	Jan 1994	A
5279294	Anderson	Jan 1994	A
5282848	Schmitt	Feb 1994	A
5282950	Dietze et al.	Feb 1994	A
5284156	Schramm et al.	Feb 1994	A
5284570	Savage et al.	Feb 1994	A
5284748	Mroczkawski et al.	Feb 1994	A
5285513	Kaufman et al.	Feb 1994	A
5285792	Sjoguist et al.	Feb 1994	A
5286362	Hoenes et al.	Feb 1994	A
5286364	Yacynych et al.	Feb 1994	A
5288636	Pollmann et al.	Feb 1994	A
5291887	Stanley et al.	Mar 1994	A
5293546	Tadros et al.	Mar 1994	A
5299571	Mastrototaro	Apr 1994	A
5304127	Kawahara et al.	Apr 1994	A
5304468	Phillips et al.	Apr 1994	A
5307263	Brown	Apr 1994	A
5309919	Snell et al.	May 1994	A
5310469	Cunningham et al.	May 1994	A
5310885	Maier et al.	May 1994	A
5312361	Zadini et al.	May 1994	A
5314450	Thompson	May 1994	A
5314471	Brauker et al.	May 1994	A
5318521	Slettenmark	Jun 1994	A
5320098	Davidson	Jun 1994	A
5320725	Gregg et al.	Jun 1994	A
5322063	Allen et al.	Jun 1994	A
5324303	Strong et al.	Jun 1994	A
5324316	Schulman et al.	Jun 1994	A
5326356	Della Valle et al.	Jul 1994	A
5326449	Cunningham	Jul 1994	A
5328460	Lord et al.	Jul 1994	A
5330521	Cohen	Jul 1994	A
5330634	Wong et al.	Jul 1994	A
5331966	Bennett et al.	Jul 1994	A
5337258	Dennis	Aug 1994	A
5337747	Neftei	Aug 1994	A
5340722	Wolfbeis et al.	Aug 1994	A
5342409	Mullet	Aug 1994	A
5342789	Chick et al.	Aug 1994	A
5343869	Pross et al.	Sep 1994	A
5344454	Clarke et al.	Sep 1994	A
5348788	White	Sep 1994	A
5350407	McClure et al.	Sep 1994	A
5352348	Young et al.	Oct 1994	A
5352351	White et al.	Oct 1994	A
5354319	Wyborny et al.	Oct 1994	A
5356348	Bellio et al.	Oct 1994	A
5356786	Heller et al.	Oct 1994	A
5358514	Schulman et al.	Oct 1994	A
5364797	Olson et al.	Nov 1994	A
5366609	White et al.	Nov 1994	A
5368028	Palti	Nov 1994	A
5368562	Blomguist et al.	Nov 1994	A
5370622	Livingston et al.	Dec 1994	A
5371687	Holmes, II et al.	Dec 1994	A
5372133	Hogen Esch	Dec 1994	A
5372719	Afeyan et al.	Dec 1994	A
5376070	Purvis et al.	Dec 1994	A
5376251	Kaneko et al.	Dec 1994	A
5377258	Bro	Dec 1994	A
5378628	Gratzel et al.	Jan 1995	A
5379238	Stark	Jan 1995	A
5380422	Negishis et al.	Jan 1995	A
5380536	Hubbell et al.	Jan 1995	A
5382346	Uenoyama et al.	Jan 1995	A
5384028	Ito	Jan 1995	A
5387327	Khan	Feb 1995	A
5390671	Lord et al.	Feb 1995	A
5391250	Cheney, II et al.	Feb 1995	A
5393903	Gratzel et al.	Feb 1995	A
5395504	Saurer et al.	Mar 1995	A
5397848	Yang et al.	Mar 1995	A
5399823	McCusker	Mar 1995	A
5400782	Beaubiah	Mar 1995	A
5408999	Singh et al.	Apr 1995	A
5410471	Alyfuku et al.	Apr 1995	A
5410474	Fox	Apr 1995	A
5411536	Armstrong	May 1995	A
5411647	Johnson et al.	May 1995	A
5413690	Kost et al.	May 1995	A
5422246	Koopal et al.	Jun 1995	A
5426032	Phillips	Jun 1995	A
5429129	Lovejoy et al.	Jul 1995	A
5431160	Wilkins	Jul 1995	A
5431691	Snell et al.	Jul 1995	A
5431921	Thombre	Jul 1995	A
5433710	Van Antwerp et al.	Jul 1995	A
5437973	Vadgama et al.	Aug 1995	A
5437999	Dieboid et al.	Aug 1995	A
5438984	Schoendorfer	Aug 1995	A
5445611	Eppstein et al.	Aug 1995	A
5445920	Saito	Aug 1995	A
5451260	Versteeg et al.	Sep 1995	A
5452173	Brannon et al.	Sep 1995	A
5453199	Afejan et al.	Sep 1995	A
5453278	Chan et al.	Sep 1995	A
5456692	Smith, Jr. et al.	Oct 1995	A
5456940	Funderburk	Oct 1995	A
5458140	Eppstein et al.	Oct 1995	A
5460618	Harreld	Oct 1995	A
5462064	D'Angelo et al.	Oct 1995	A
5462525	Srisathapat et al.	Oct 1995	A
5462645	Albery et al.	Oct 1995	A
5466218	Srisathapat et al.	Nov 1995	A
5469846	Khan	Nov 1995	A
5472317	Field et al.	Dec 1995	A
5476460	Montalvo	Dec 1995	A
5477855	Schindler et al.	Dec 1995	A
5482473	Lord et al.	Jan 1996	A
5484404	Schulman et al.	Jan 1996	A
5487751	Radons et al.	Jan 1996	A
5491474	Suni et al.	Feb 1996	A
5494562	Maley et al.	Feb 1996	A
5496453	Uenoyama et al.	Mar 1996	A
5497772	Schulman et al.	Mar 1996	A
5501665	Jhuboo et al.	Mar 1996	A
5501956	Wada et al.	Mar 1996	A
5505709	Funderburk	Apr 1996	A
5505713	Van Antwerp et al.	Apr 1996	A
5507288	Bocker et al.	Apr 1996	A
5508171	Walling et al.	Apr 1996	A
5509410	Hill et al.	Apr 1996	A
5514103	Srisathapat et al.	May 1996	A
5514253	Davis et al.	May 1996	A
5518006	Mawhirt et al.	May 1996	A
5520787	Hanagan et al.	May 1996	A
5522865	Schulman et al.	Jun 1996	A
5525511	D'Costa	Jun 1996	A
5526120	Jina et al.	Jun 1996	A
5527307	Srisathapat et al.	Jun 1996	A
5529676	Maley et al.	Jun 1996	A
5531878	Vadgama et al.	Jul 1996	A
5538007	Gorman	Jul 1996	A
5538511	Van Antwerp et al.	Jul 1996	A
5540828	Yacynych	Jul 1996	A
5545152	Funderburk et al.	Aug 1996	A
5545191	Mann et al.	Aug 1996	A
5545220	Andrews et al.	Aug 1996	A
5545223	Neuenfeldt et al.	Aug 1996	A
5549113	Halleck et al.	Aug 1996	A
5549115	Morgan et al.	Aug 1996	A
5549675	Neuenfeldt et al.	Aug 1996	A
5552027	Birkle et al.	Sep 1996	A
5554166	Lange et al.	Sep 1996	A
5556524	Albers	Sep 1996	A
5558638	Evers et al.	Sep 1996	A
5560357	Faupei et al.	Oct 1996	A
5562713	Silvian	Oct 1996	A
5564439	Picha	Oct 1996	A
5565085	Ikeda et al.	Oct 1996	A
5567302	Song et al.	Oct 1996	A
5568806	Cheney, II et al.	Oct 1996	A
5569186	Lord et al.	Oct 1996	A
5569212	Brown	Oct 1996	A
5569462	Martinson et al.	Oct 1996	A
5571395	Park et al.	Nov 1996	A
5573506	Vasko	Nov 1996	A
5573647	Maley et al.	Nov 1996	A
5575895	Ikeda et al.	Nov 1996	A
5575930	Tietje-Girault et al.	Nov 1996	A
5580527	Bell et al.	Dec 1996	A
5580794	Allen	Dec 1996	A
5582184	Erickson et al.	Dec 1996	A
5582593	Hultman	Dec 1996	A
5582697	Ikeda et al.	Dec 1996	A
5582698	Flaherty et al.	Dec 1996	A
5584813	Livingston et al.	Dec 1996	A
5584876	Bruchman et al.	Dec 1996	A
5586553	Halli et al.	Dec 1996	A
5587273	Yan et al.	Dec 1996	A
5589326	Deng et al.	Dec 1996	A
5589563	Ward et al.	Dec 1996	A
5590651	Shaffer et al.	Jan 1997	A
5593440	Brauker et al.	Jan 1997	A
5593852	Heller et al.	Jan 1997	A
5594906	Holmes, II et al.	Jan 1997	A
5596150	Arndy et al.	Jan 1997	A
5596994	Bro	Jan 1997	A
5601435	Quy	Feb 1997	A
5601694	Maley et al.	Feb 1997	A
5605152	Slate et al.	Feb 1997	A
5607565	Azarnia et al.	Mar 1997	A
5611900	Worden et al.	Mar 1997	A
5615091	Palatnik	Mar 1997	A
5615671	Schoonen et al.	Apr 1997	A
5616222	Maley et al.	Apr 1997	A
5617851	Lipkovker	Apr 1997	A
5623925	Swenson et al.	Apr 1997	A
5624537	Turner et al.	Apr 1997	A
5628309	Brown	May 1997	A
5628310	Rao et al.	May 1997	A
5628890	Carter et al.	May 1997	A
5629981	Nerlikar	May 1997	A
5637095	Nason et al.	Jun 1997	A
5640764	Strojnik	Jun 1997	A
5640954	Pfeiffer et al.	Jun 1997	A
5643212	Coutre et al.	Jul 1997	A
5647853	Feldmann et al.	Jul 1997	A
5650062	Ikeda et al.	Jul 1997	A
5651767	Schulman et al.	Jul 1997	A
5651869	Yoshioka et al.	Jul 1997	A
5653735	Chen et al.	Aug 1997	A
5653756	Clarke et al.	Aug 1997	A
5653863	Genshaw et al.	Aug 1997	A
5658250	Blomguist et al.	Aug 1997	A
5658330	Carlisle et al.	Aug 1997	A
5660163	Schulman et al.	Aug 1997	A
5662694	Lidman et al.	Sep 1997	A
5665065	Colman et al.	Sep 1997	A
5667983	Abel et al.	Sep 1997	A
5670031	Hintsche et al.	Sep 1997	A
5673691	Abrams et al.	Oct 1997	A
5678571	Brown	Oct 1997	A
5679690	Andre et al.	Oct 1997	A
5680858	Hansen et al.	Oct 1997	A
5682233	Brinda	Oct 1997	A
5686717	Knowles et al.	Nov 1997	A
5686829	Girault	Nov 1997	A
5695473	Olsen	Dec 1997	A
5695623	Michel et al.	Dec 1997	A
5695949	Galen et al.	Dec 1997	A
5701894	Cherry et al.	Dec 1997	A
5704354	Priedel et al.	Jan 1998	A
5704366	Tacklind et al.	Jan 1998	A
5704922	Brown	Jan 1998	A
5706807	Picha	Jan 1998	A
5707502	McCaffrey et al.	Jan 1998	A
5708247	McAleer et al.	Jan 1998	A
5710630	Essenpreis et al.	Jan 1998	A
5711001	Bussan et al.	Jan 1998	A
5711297	Iliff et al.	Jan 1998	A
5711861	Ward et al.	Jan 1998	A
5711862	Sakoda et al.	Jan 1998	A
5711868	Maley et al.	Jan 1998	A
5713888	Neuenfeldt et al.	Feb 1998	A
5714123	Sohrab	Feb 1998	A
5718234	Warden et al.	Feb 1998	A
5720733	Brown	Feb 1998	A
5720862	Hamamoto et al.	Feb 1998	A
5721783	Anderson	Feb 1998	A
5722397	Eppstein	Mar 1998	A
5727548	Hill et al.	Mar 1998	A
5730124	Yamauchi	Mar 1998	A
5730654	Brown	Mar 1998	A
5733336	Neuenfeldt et al.	Mar 1998	A
5735273	Kurnik et al.	Apr 1998	A
5735285	Albert et al.	Apr 1998	A
5741211	Renirie et al.	Apr 1998	A
5741330	Brauker et al.	Apr 1998	A
5741688	Oxenboll et al.	Apr 1998	A
5746217	Erickson et al.	May 1998	A
5748103	Flach et al.	May 1998	A
5749907	Mann	May 1998	A
5750926	Schulman et al.	May 1998	A
5756632	Ward et al.	May 1998	A
5770028	Maley et al.	Jun 1998	A
5771001	Cobb	Jun 1998	A
5771890	Tamada	Jun 1998	A
5772586	Heinonen et al.	Jun 1998	A
5777060	Van Antwerp	Jul 1998	A
5778882	Raymond et al.	Jul 1998	A
5779665	Mastrototaro et al.	Jul 1998	A
5782814	Brown et al.	Jul 1998	A
5782912	Brauker et al.	Jul 1998	A
5785681	Indravudh	Jul 1998	A
5786439	Van Antwerp et al.	Jul 1998	A
5786584	Button et al.	Jul 1998	A
5787900	Butler et al.	Aug 1998	A
5788678	Van Antwerp	Aug 1998	A
5791344	Schulman et al.	Aug 1998	A
5792117	Brown	Aug 1998	A
5795774	Matsumoto et al.	Aug 1998	A
5798065	Picha	Aug 1998	A
5800387	Duffy et al.	Sep 1998	A
5800420	Gross et al.	Sep 1998	A
5800529	Brauker et al.	Sep 1998	A
5804048	Wong et al.	Sep 1998	A
5807315	VanAntwerp et al.	Sep 1998	A
5807375	Gross et al.	Sep 1998	A
5807406	Brauker et al.	Sep 1998	A
5811487	Schulz, Jr. et al.	Sep 1998	A
5814599	Mitragotri et al.	Sep 1998	A
5820551	Hill et al.	Oct 1998	A
5820570	Erickson et al.	Oct 1998	A
5820622	Gross et al.	Oct 1998	A
5822715	Worthington et al.	Oct 1998	A
5825488	Kohl et al.	Oct 1998	A
5827179	Lichter et al.	Oct 1998	A
5827180	Goodman	Oct 1998	A
5827183	Kurnik et al.	Oct 1998	A
5827184	Netherly et al.	Oct 1998	A
5828943	Brown	Oct 1998	A
5830341	Gilmartin	Nov 1998	A
5832448	Brown	Nov 1998	A
5833603	Kovacs et al.	Nov 1998	A
5834224	Ruger et al.	Nov 1998	A
5836887	Oka et al.	Nov 1998	A
5836989	Shelton	Nov 1998	A
5837454	Cozzette et al.	Nov 1998	A
5837546	Allen et al.	Nov 1998	A
5837728	Purcell	Nov 1998	A
5840020	Heinonen et al.	Nov 1998	A
5840240	Stenoien et al.	Nov 1998	A
5842983	Abel et al.	Dec 1998	A
5843140	Strojnik	Dec 1998	A
5846702	Deng et al.	Dec 1998	A
5846744	Athey et al.	Dec 1998	A
5851197	Marano et al.	Dec 1998	A
5854078	Asher et al.	Dec 1998	A
5854189	Kruse et al.	Dec 1998	A
5857967	Frid et al.	Jan 1999	A
5857983	Douglas et al.	Jan 1999	A
5860917	Comanor et al.	Jan 1999	A
5861009	Armstrong et al.	Jan 1999	A
5861019	Sun et al.	Jan 1999	A
5862803	Besson et al.	Jan 1999	A
5871465	Vasko	Feb 1999	A
5871514	Wiklund et al.	Feb 1999	A
5872713	Douglas et al.	Feb 1999	A
5872820	Upadrasta	Feb 1999	A
5876484	Raskin et al.	Mar 1999	A
5879163	Brown et al.	Mar 1999	A
5879311	Duchon et al.	Mar 1999	A
5879373	Roper et al.	Mar 1999	A
5880829	Kauhaniemi et al.	Mar 1999	A
5882494	Van Antwerp	Mar 1999	A
5885211	Eppstein et al.	Mar 1999	A
5885245	Lynch et al.	Mar 1999	A
5887133	Brown et al.	Mar 1999	A
5895371	Levitas et al.	Apr 1999	A
5897493	Brown	Apr 1999	A
5897578	Wiklund et al.	Apr 1999	A
5898025	Burg et al.	Apr 1999	A
5899855	Brown	May 1999	A
5899931	Deschamp et al.	May 1999	A
5902234	Webb	May 1999	A
5904708	Goedeke	May 1999	A
5913310	Brown	Jun 1999	A
5913827	Gorman	Jun 1999	A
5913998	Butler et al.	Jun 1999	A
5914026	Blubaugh, Jr. et al.	Jun 1999	A
5916445	Hjerten et al.	Jun 1999	A
5917346	Gord	Jun 1999	A
5918603	Brown	Jul 1999	A
5919215	Wildund et al.	Jul 1999	A
5925021	Castellano et al.	Jul 1999	A
5928130	Schmidt	Jul 1999	A
5931791	Saltzstein et al.	Aug 1999	A
5931814	Alex et al.	Aug 1999	A
5933136	Brown	Aug 1999	A
5935099	Peterson et al.	Aug 1999	A
5935785	Reber et al.	Aug 1999	A
5940801	Brown	Aug 1999	A
5942979	Luppino	Aug 1999	A
5945345	Blatt et al.	Aug 1999	A
5947749	Rathburn	Sep 1999	A
5947921	Johnson et al.	Sep 1999	A
5948512	Kubota et al.	Sep 1999	A
5950632	Reber et al.	Sep 1999	A
5951300	Brown	Sep 1999	A
5951492	Douglas et al.	Sep 1999	A
5951521	Mastrototaro et al.	Sep 1999	A
5951836	McAleer et al.	Sep 1999	A
5954641	Kehr et al.	Sep 1999	A
5954643	Van Antwerp	Sep 1999	A
5954685	Tierny	Sep 1999	A
5954700	Kovelman	Sep 1999	A
5956501	Brown	Sep 1999	A
5957854	Besson et al.	Sep 1999	A
5957890	Mann et al.	Sep 1999	A
5957903	Mirzaee et al.	Sep 1999	A
5957958	Schulman et al.	Sep 1999	A
5959050	Mosbach et al.	Sep 1999	A
5960403	Brown	Sep 1999	A
5961451	Reber et al.	Oct 1999	A
5964804	Brauker et al.	Oct 1999	A
5964993	Blubaugh, Jr. et al.	Oct 1999	A
5965380	Heller et al.	Oct 1999	A
5967975	Ridgeway	Oct 1999	A
5968839	Blatt et al.	Oct 1999	A
5971922	Arita et al.	Oct 1999	A
5971941	Simons et al.	Oct 1999	A
5974124	Schlueter, Jr. et al.	Oct 1999	A
5976085	Kimball et al.	Nov 1999	A
5977476	Guha et al.	Nov 1999	A
5981294	Blatt et al.	Nov 1999	A
5985129	Gough et al.	Nov 1999	A
5987352	Klein et al.	Nov 1999	A
5989409	Kurnik et al.	Nov 1999	A
5991729	Barry et al.	Nov 1999	A
5994476	Shin et al.	Nov 1999	A
5995860	Sun et al.	Nov 1999	A
5997476	Brown	Dec 1999	A
5999848	Gord et al.	Dec 1999	A
5999849	Gord et al.	Dec 1999	A
6001067	Shults et al.	Dec 1999	A
6001471	Bries et al.	Dec 1999	A
6002954	Van Antwerp et al.	Dec 1999	A
6002961	Mitragotri et al.	Dec 1999	A
6004441	Fujiwara et al.	Dec 1999	A
6007845	Domb	Dec 1999	A
6011984	Van Antwerp et al.	Jan 2000	A
6013113	Mika	Jan 2000	A
6014577	Henning et al.	Jan 2000	A
6016448	Busacker et al.	Jan 2000	A
6017435	Hassard et al.	Jan 2000	A
6018678	Mitragotri et al.	Jan 2000	A
6023629	Tamada	Feb 2000	A
6024699	Surwit et al.	Feb 2000	A
6026320	Carlson et al.	Feb 2000	A
6027459	Sham et al.	Feb 2000	A
6027692	Galen et al.	Feb 2000	A
6032059	Henning et al.	Feb 2000	A
6032119	Brown et al.	Feb 2000	A
6032199	Lim et al.	Feb 2000	A
6033866	Guo et al.	Mar 2000	A
6035237	Schulman et al.	Mar 2000	A
6039688	Douglas et al.	Mar 2000	A
6040194	Chick et al.	Mar 2000	A
6041253	Kost et al.	Mar 2000	A
6043437	Schulman et al.	Mar 2000	A
6048691	Maracas	Apr 2000	A
6049727	Crothall	Apr 2000	A
6051372	Bayerl et al.	Apr 2000	A
D424696	Ray et al.	May 2000	S
6056718	Funderburk et al.	May 2000	A
6057377	Sasaki et al.	May 2000	A
6063459	Velte	May 2000	A
6063637	Arnold et al.	May 2000	A
6066083	Slater et al.	May 2000	A
6066243	Anderson et al.	May 2000	A
6066448	Wohlstadter et al.	May 2000	A
6067474	Schulman et al.	May 2000	A
6068615	Brown et al.	May 2000	A
D426638	Ray et al.	Jun 2000	S
D427312	Douglas	Jun 2000	S
6071249	Cunningham et al.	Jun 2000	A
6071251	Cunningham et al.	Jun 2000	A
6071294	Simons et al.	Jun 2000	A
6071391	Gotoh et al.	Jun 2000	A
6071406	Tsou	Jun 2000	A
6073049	Alt et al.	Jun 2000	A
6081735	Diab et al.	Jun 2000	A
6081736	Colvin et al.	Jun 2000	A
6083710	Heller et al.	Jul 2000	A
6088608	Schulman et al.	Jul 2000	A
6091975	Daddona et al.	Jul 2000	A
6091976	Pfeiffer et al.	Jul 2000	A
6093156	Cunningham et al.	Jul 2000	A
6093167	Houben et al.	Jul 2000	A
6093172	Funderburk et al.	Jul 2000	A
6097831	Wieck et al.	Aug 2000	A
6099484	Douglas et al.	Aug 2000	A
6101478	Brown	Aug 2000	A
6103033	Say et al.	Aug 2000	A
6103533	Hassard et al.	Aug 2000	A
6106780	Douglas et al.	Aug 2000	A
6107083	Collins et al.	Aug 2000	A
6110148	Brown et al.	Aug 2000	A
6110152	Kovelman	Aug 2000	A
6113578	Brown	Sep 2000	A
6115634	Donders et al.	Sep 2000	A
6117290	Say	Sep 2000	A
6119028	Schulman et al.	Sep 2000	A
6120676	Heller et al.	Sep 2000	A
6121009	Heller et al.	Sep 2000	A
6122351	Schlueter, Jr. et al.	Sep 2000	A
6122536	Sun et al.	Sep 2000	A
6125978	Ando et al.	Oct 2000	A
6134461	Say et al.	Oct 2000	A
6134504	Douglas et al.	Oct 2000	A
6135978	Houben et al.	Oct 2000	A
6139718	Kurnik et al.	Oct 2000	A
6141573	Kurnik et al.	Oct 2000	A
6142939	Eppstein et al.	Nov 2000	A
6142972	Cheikh	Nov 2000	A
6143164	Heller et al.	Nov 2000	A
6144837	Quy	Nov 2000	A
6144869	Berner et al.	Nov 2000	A
6144922	Douglas et al.	Nov 2000	A
6148094	Kinsella	Nov 2000	A
6150128	Uretsky	Nov 2000	A
6151586	Brown	Nov 2000	A
6153062	Saito et al.	Nov 2000	A
6153069	Pottgen et al.	Nov 2000	A
6154675	Juran et al.	Nov 2000	A
6159147	Lichter et al.	Dec 2000	A
6161095	Brown	Dec 2000	A
6162611	Heller et al.	Dec 2000	A
6162639	Douglas	Dec 2000	A
6167362	Brown et al.	Dec 2000	A
6167614	Tuttle et al.	Jan 2001	B1
6168563	Brown	Jan 2001	B1
6170318	Lewis	Jan 2001	B1
6171237	Avitall et al.	Jan 2001	B1
6175752	Say et al.	Jan 2001	B1
6180416	Kurnik et al.	Jan 2001	B1
6186145	Brown	Feb 2001	B1
6187062	Oweis et al.	Feb 2001	B1
6189536	Martinez et al.	Feb 2001	B1
6192891	Gravel et al.	Feb 2001	B1
6193873	Ohara et al.	Feb 2001	B1
D439242	Brown et al.	Mar 2001	S
6196970	Brown	Mar 2001	B1
6198957	Green	Mar 2001	B1
6200265	Walsh et al.	Mar 2001	B1
6200772	Vadgama et al.	Mar 2001	B1
6201979	Kurnik et al.	Mar 2001	B1
6201980	Darrow et al.	Mar 2001	B1
6201993	Kruse et al.	Mar 2001	B1
6206841	Cunningham et al.	Mar 2001	B1
6206856	Mahurkar	Mar 2001	B1
6207400	Kwon	Mar 2001	B1
6208894	Schulman et al.	Mar 2001	B1
6210272	Brown	Apr 2001	B1
6210976	Sabbadini	Apr 2001	B1
6212416	Ward et al.	Apr 2001	B1
6212424	Robinson	Apr 2001	B1
6214185	Offenbacher et al.	Apr 2001	B1
6219565	Cupp et al.	Apr 2001	B1
6219574	Cormier et al.	Apr 2001	B1
6223083	Rosar	Apr 2001	B1
6223471	Barber	May 2001	B1
6224745	Baltruschat	May 2001	B1
6230059	Duffin	May 2001	B1
6231879	Li et al.	May 2001	B1
6232130	Wolf	May 2001	B1
6232370	Kubota et al.	May 2001	B1
6232783	Merrill	May 2001	B1
6233080	Brenner et al.	May 2001	B1
6233471	Berner et al.	May 2001	B1
6233539	Brown	May 2001	B1
6239925	Ardrey et al.	May 2001	B1
6241704	Peterson et al.	Jun 2001	B1
6241862	McAleer et al.	Jun 2001	B1
6241863	Monbouguette	Jun 2001	B1
6246330	Nielsen	Jun 2001	B1
6246992	Brown	Jun 2001	B1
6248065	Brown	Jun 2001	B1
6248067	Causey, III et al.	Jun 2001	B1
6248093	Moberg	Jun 2001	B1
6249809	Bro	Jun 2001	B1
6251260	Heller et al.	Jun 2001	B1
6251280	Dai et al.	Jun 2001	B1
6252032	Van Antwerp et al.	Jun 2001	B1
6253804	Safabash	Jul 2001	B1
6254586	Mann et al.	Jul 2001	B1
6256522	Schultz	Jul 2001	B1
6256643	Cork et al.	Jul 2001	B1
6259587	Sheldon et al.	Jul 2001	B1
6259937	Schulman et al.	Jul 2001	B1
6260022	Brown	Jul 2001	B1
6264825	Blackburn et al.	Jul 2001	B1
6266645	Simpson	Jul 2001	B1
6267724	Taylor	Jul 2001	B1
6268161	Han et al.	Jul 2001	B1
6268913	Rising	Jul 2001	B1
6270445	Dean, Jr. et al.	Aug 2001	B1
6270455	Brown	Aug 2001	B1
6272364	Kurnik	Aug 2001	B1
6272480	Tresp et al.	Aug 2001	B1
6274285	Gries et al.	Aug 2001	B1
6274686	Mosbach	Aug 2001	B1
6275717	Gross et al.	Aug 2001	B1
6280416	Van Antwerp et al.	Aug 2001	B1
6280587	Matsumoto	Aug 2001	B1
6281006	Heller et al.	Aug 2001	B1
6283943	Dy et al.	Sep 2001	B1
6284126	Kurnik et al.	Sep 2001	B1
6284478	Heller et al.	Sep 2001	B1
6285897	Kilcoyne et al.	Sep 2001	B1
6292783	Rohler et al.	Sep 2001	B1
6293925	Safabash et al.	Sep 2001	B1
6294281	Heller	Sep 2001	B1
6295463	Stenzler	Sep 2001	B1
6295506	Heinonen et al.	Sep 2001	B1
6298254	Tamada	Oct 2001	B2
6299578	Kurnik et al.	Oct 2001	B1
6299757	Feldman et al.	Oct 2001	B1
6300002	Webb et al.	Oct 2001	B1
6301499	Carlson et al.	Oct 2001	B1
6304766	Colvin, Jr. et al.	Oct 2001	B1
6309351	Kurnik et al.	Oct 2001	B1
6309384	Harrington et al.	Oct 2001	B1
6309526	Fujiwara et al.	Oct 2001	B1
6309884	Cooper et al.	Oct 2001	B1
6310110	Markowitz et al.	Oct 2001	B1
6315721	Schulman et al.	Nov 2001	B2
6315738	Nishikawa et al.	Nov 2001	B1
6319540	Van Antwerp et al.	Nov 2001	B1
6319566	Polanyi et al.	Nov 2001	B1
6320357	Peters et al.	Nov 2001	B1
6324428	Weinberg et al.	Nov 2001	B1
6325978	Labuda et al.	Dec 2001	B1
6325979	Hahn et al.	Dec 2001	B1
6326160	Dunn et al.	Dec 2001	B1
6329161	Heller et al.	Dec 2001	B1
6329929	Weijand et al.	Dec 2001	B1
6330426	Brown et al.	Dec 2001	B2
6330464	Colvin, Jr. et al.	Dec 2001	B1
6331518	Hemm et al.	Dec 2001	B2
6334778	Brown	Jan 2002	B1
6336900	Alleckson et al.	Jan 2002	B1
6338790	Feldman et al.	Jan 2002	B1
6340421	Vachon et al.	Jan 2002	B1
6341232	Conn et al.	Jan 2002	B1
6343225	Clark, Jr.	Jan 2002	B1
6356776	Berner et al.	Mar 2002	B1
6358237	Paukovits et al.	Mar 2002	B1
6360888	McIvor et al.	Mar 2002	B1
6361960	Pliszka et al.	Mar 2002	B1
6363282	Nichols et al.	Mar 2002	B1
6365670	Fry	Apr 2002	B1
6366793	Bell et al.	Apr 2002	B1
6366794	Moussy et al.	Apr 2002	B1
6368141	Van Antwerp et al.	Apr 2002	B1
6368274	Van Antwerp et al.	Apr 2002	B1
6370410	Kurnik et al.	Apr 2002	B2
6379301	Worthington et al.	Apr 2002	B1
6379317	Kintzig et al.	Apr 2002	B1
6383767	Polak	May 2002	B1
6387048	Schulman et al.	May 2002	B1
6389461	Shah	May 2002	B1
6391643	Chen et al.	May 2002	B1
6393318	Conn et al.	May 2002	B1
6398562	Butler et al.	Jun 2002	B1
6398727	Bui et al.	Jun 2002	B1
6402689	Scarantino et al.	Jun 2002	B1
6402691	Peddicord et al.	Jun 2002	B1
6405066	Essenpreis et al.	Jun 2002	B1
6406066	Uegene	Jun 2002	B1
6406426	Reuss et al.	Jun 2002	B1
6409674	Brockway et al.	Jun 2002	B1
6413393	Van Antwerp et al.	Jul 2002	B1
6416471	Kumar et al.	Jul 2002	B1
6418332	Mastrototaro et al.	Jul 2002	B1
6418346	Nelson et al.	Jul 2002	B1
6424847	Mastrototaro et al.	Jul 2002	B1
6424867	Snell et al.	Jul 2002	B1
6427088	Bowman, IV et al.	Jul 2002	B1
6434409	Pfeiffer et al.	Aug 2002	B1
6438414	Conn et al.	Aug 2002	B1
6440068	Brown et al.	Aug 2002	B1
6442433	Linberg	Aug 2002	B1
6442637	Hawkins et al.	Aug 2002	B1
6443942	Van Antwerp et al.	Sep 2002	B2
6447448	Ishikawa et al.	Sep 2002	B1
6447542	Weadock	Sep 2002	B1
6454705	Cosentino et al.	Sep 2002	B1
6454710	Ballerstadt et al.	Sep 2002	B1
6459917	Gowda et al.	Oct 2002	B1
6461496	Feldman et al.	Oct 2002	B1
6462162	Van Antwerp et al.	Oct 2002	B2
6464687	Ishikawa et al.	Oct 2002	B1
6464848	Matsumoto	Oct 2002	B1
6466810	Ward et al.	Oct 2002	B1
6468222	Mault et al.	Oct 2002	B1
6469526	Franklin	Oct 2002	B1
6471645	Warkentin et al.	Oct 2002	B1
6471689	Joseph et al.	Oct 2002	B1
6472122	Schulman et al.	Oct 2002	B1
6475180	Peterson et al.	Nov 2002	B2
6475750	Han et al.	Nov 2002	B1
6477392	Honigs et al.	Nov 2002	B1
6477395	Schulman et al.	Nov 2002	B2
6478736	Mault	Nov 2002	B1
6480730	Darrow et al.	Nov 2002	B2
6481440	Gielen et al.	Nov 2002	B2
6482158	Mault	Nov 2002	B2
6482604	Kwon	Nov 2002	B2
6484045	Holker et al.	Nov 2002	B1
6484046	Say et al.	Nov 2002	B1
6485138	Kubota et al.	Nov 2002	B1
6485465	Moberg et al.	Nov 2002	B2
6494830	Wessel	Dec 2002	B1
6496728	Li et al.	Dec 2002	B2
6498043	Schulman et al.	Dec 2002	B1
6498941	Jackson	Dec 2002	B1
6505059	Kollias et al.	Jan 2003	B1
6512939	Colvin et al.	Jan 2003	B1
6513532	Mault et al.	Feb 2003	B2
6514718	Heller et al.	Feb 2003	B2
6515593	Stark et al.	Feb 2003	B1
6519241	Theimer	Feb 2003	B1
6520326	McIvor et al.	Feb 2003	B2
6520997	Pekkarinen et al.	Feb 2003	B1
6526298	Khalil et al.	Feb 2003	B1
6527729	Turcott	Mar 2003	B1
6528584	Kennedy et al.	Mar 2003	B2
6529755	Kurnik et al.	Mar 2003	B2
6529772	Carlson et al.	Mar 2003	B2
6530915	Eppstein et al.	Mar 2003	B1
6534322	Sabbadini	Mar 2003	B1
6534323	Sabbadini	Mar 2003	B1
6535753	Raskas	Mar 2003	B1
6537243	Henning et al.	Mar 2003	B1
6537318	Ita et al.	Mar 2003	B1
6540672	Simonsen et al.	Apr 2003	B1
6540675	Aceti et al.	Apr 2003	B2
6541107	Zhong et al.	Apr 2003	B1
6544212	Galley et al.	Apr 2003	B2
6545085	Kilgour et al.	Apr 2003	B2
6546232	Erbel et al.	Apr 2003	B1
6546268	Ishikawa et al.	Apr 2003	B1
6546269	Kurnik	Apr 2003	B1
6547839	Zhang et al.	Apr 2003	B2
6549796	Sohrab	Apr 2003	B2
6551276	Mann et al.	Apr 2003	B1
6551494	Feldman et al.	Apr 2003	B1
6551496	Moles et al.	Apr 2003	B1
6553244	Lesho et al.	Apr 2003	B2
6554798	Mann et al.	Apr 2003	B1
6558320	Causey, III et al.	May 2003	B1
6558321	Bird et al.	May 2003	B1
6558351	Steil et al.	May 2003	B1
6560471	Heller et al.	May 2003	B1
6561978	Conn et al.	May 2003	B1
6562001	Lebel et al.	May 2003	B2
6564105	Starkweather et al.	May 2003	B2
6565509	Say et al.	May 2003	B1
6569521	Sheridan et al.	May 2003	B1
6571128	Lebel et al.	May 2003	B2
6571200	Mault	May 2003	B1
6572545	Knobbe et al.	Jun 2003	B2
6574490	Abbink et al.	Jun 2003	B2
6575905	Knobbe et al.	Jun 2003	B2
6576101	Heller et al.	Jun 2003	B1
6576117	Iketaki et al.	Jun 2003	B1
6577899	Lebel et al.	Jun 2003	B2
6579231	Phipps	Jun 2003	B1
6579498	Eglise	Jun 2003	B1
6579690	Bonnecaze et al.	Jun 2003	B1
6584335	Haar et al.	Jun 2003	B1
6585644	Lebel et al.	Jul 2003	B2
6585675	OMahony et al.	Jul 2003	B1
6585763	Keilman et al.	Jul 2003	B1
6587705	Kim et al.	Jul 2003	B1
6588644	Simon	Jul 2003	B2
6589205	Meadows	Jul 2003	B1
6589229	Connelly et al.	Jul 2003	B1
6591125	Buse et al.	Jul 2003	B1
6591126	Roeper et al.	Jul 2003	B2
6594514	Berner et al.	Jul 2003	B2
6595919	Berner et al.	Jul 2003	B2
6595929	Stivoric et al.	Jul 2003	B2
6602191	Quy	Aug 2003	B2
6602678	Kwon et al.	Aug 2003	B2
6602909	Jarowski	Aug 2003	B1
6605072	Struys et al.	Aug 2003	B2
6605200	Mao et al.	Aug 2003	B1
6605201	Mao et al.	Aug 2003	B1
6607509	Bobroff et al.	Aug 2003	B2
6607658	Heller et al.	Aug 2003	B1
6610012	Mault	Aug 2003	B2
6612306	Mault	Sep 2003	B1
6612984	Kerr	Sep 2003	B1
6613379	Ward et al.	Sep 2003	B2
6615078	Burson et al.	Sep 2003	B1
6616819	Liamos et al.	Sep 2003	B1
6618603	Varalli et al.	Sep 2003	B2
6618934	Feldman et al.	Sep 2003	B1
6620106	Mault	Sep 2003	B2
6627058	Chan	Sep 2003	B1
6629934	Mault et al.	Oct 2003	B2
6633772	Ford et al.	Oct 2003	B2
6635014	Starkweather et al.	Oct 2003	B2
6635167	Richards et al.	Oct 2003	B1
6641533	Causey, III et al.	Nov 2003	B2
6642015	Vachon et al.	Nov 2003	B2
6644321	Behm	Nov 2003	B1
6645142	Braig et al.	Nov 2003	B2
6645181	Lavi et al.	Nov 2003	B1
6648821	Lebel et al.	Nov 2003	B2
6653091	Dunn et al.	Nov 2003	B1
6654625	Say et al.	Nov 2003	B1
6659948	Lebel et al.	Dec 2003	B2
6668196	Villegas et al.	Dec 2003	B1
6671554	Gibson et al.	Dec 2003	B2
6673596	Sayler et al.	Jan 2004	B1
6673625	Satcher, Jr. et al.	Jan 2004	B2
6682938	Satcher, Jr. et al.	Jan 2004	B1
6683040	Bragulla et al.	Jan 2004	B2
6683535	Utke	Jan 2004	B1
6687522	Tamada	Feb 2004	B2
6687546	Lebel et al.	Feb 2004	B2
6689056	Kilcoyne et al.	Feb 2004	B1
6689091	Bui et al.	Feb 2004	B2
6689265	Heller et al.	Feb 2004	B2
6693069	Korber et al.	Feb 2004	B2
6694158	Polak	Feb 2004	B2
6694191	Starkweather et al.	Feb 2004	B2
6695860	Ward et al.	Feb 2004	B1
6699188	Wessel	Mar 2004	B2
6699218	Flaherly et al.	Mar 2004	B2
6699383	Lemire et al.	Mar 2004	B2
6702857	Brauker et al.	Mar 2004	B2
6704587	Kumar et al.	Mar 2004	B1
6705883	Tam et al.	Mar 2004	B1
6708049	Berson et al.	Mar 2004	B1
6711423	Colvin, Jr.	Mar 2004	B2
6721587	Gough	Apr 2004	B2
6723046	Lichtenstein et al.	Apr 2004	B2
6728560	Kollias et al.	Apr 2004	B2
6730200	Stewert et al.	May 2004	B1
6731976	Penn et al.	May 2004	B2
6733446	Lebel et al.	May 2004	B2
6734162	Van Antwerp et al.	May 2004	B2
6735551	Voegeli et al.	May 2004	B2
6736777	Kim et al.	May 2004	B2
6737401	Kim et al.	May 2004	B2
6738654	Sohrab	May 2004	B2
6740075	Lebel et al.	May 2004	B2
6741163	Roberts	May 2004	B1
6741876	Scecina et al.	May 2004	B1
6741877	Shults et al.	May 2004	B1
6749587	Flaherty	Jun 2004	B2
6750311	Van Antwerp et al.	Jun 2004	B1
6758810	Lebel et al.	Jul 2004	B2
6766183	Walsh et al.	Jul 2004	B2
6766201	Von Arx et al.	Jul 2004	B2
6768425	Flaherty et al.	Jul 2004	B2
6770030	Schaupp et al.	Aug 2004	B1
6770729	Van Antwerp et al.	Aug 2004	B2
6771995	Kurnik et al.	Aug 2004	B2
6773563	Matsumoto	Aug 2004	B2
6773565	Kunimoto et al.	Aug 2004	B2
6780297	Matsumoto et al.	Aug 2004	B2
6780871	Glick et al.	Aug 2004	B2
6784274	Van Antwerp et al.	Aug 2004	B2
6790178	Mault et al.	Sep 2004	B1
6793802	Lee et al.	Sep 2004	B2
6794195	Colvin, Jr.	Sep 2004	B2
6799149	Hartlaub	Sep 2004	B2
6800451	Daniloff et al.	Oct 2004	B2
6801041	Karinka et al.	Oct 2004	B2
6801420	Talbot et al.	Oct 2004	B2
6802957	Jung et al.	Oct 2004	B2
6804544	Van Antwerp et al.	Oct 2004	B2
6809507	Morgan et al.	Oct 2004	B2
6809653	Mann et al.	Oct 2004	B1
6810290	Lebel et al.	Oct 2004	B2
6811533	Lebel et al.	Nov 2004	B2
6811534	Bowman, IV et al.	Nov 2004	B2
6811659	Vachon	Nov 2004	B2
6812031	Carlsson	Nov 2004	B1
6813516	Ujhelyi et al.	Nov 2004	B2
6813519	Lebel et al.	Nov 2004	B2
6815186	Clark, Jr.	Nov 2004	B2
6816742	Kim et al.	Nov 2004	B2
6835553	Han et al.	Dec 2004	B2
RE38681	Kurnik et al.	Jan 2005	E
6840912	Kloepfer et al.	Jan 2005	B2
6844023	Schulman et al.	Jan 2005	B2
6849045	Iliff	Feb 2005	B2
6849237	Housefield et al.	Feb 2005	B2
6850790	Berner et al.	Feb 2005	B2
6852500	Hoss et al.	Feb 2005	B1
6852694	Van Antwerp et al.	Feb 2005	B2
6853854	Proniewicz et al.	Feb 2005	B1
6855115	Fonseca et al.	Feb 2005	B2
6856928	Harmon	Feb 2005	B2
6858403	Han et al.	Feb 2005	B2
6862465	Shults et al.	Mar 2005	B2
6862466	Ackerman	Mar 2005	B2
6872200	Mann et al.	Mar 2005	B2
6873268	Lebel et al.	Mar 2005	B2
6875386	Ward et al.	Apr 2005	B1
6879849	Begic	Apr 2005	B2
6881551	Heller et al.	Apr 2005	B2
6882940	Potts et al.	Apr 2005	B2
6885883	Parris et al.	Apr 2005	B2
6891317	Pci et al.	May 2005	B2
6891936	Kai et al.	May 2005	B2
6892085	McIvor et al.	May 2005	B2
6893552	Wang et al.	May 2005	B1
6895263	Shin et al.	May 2005	B2
6899683	Mault et al.	May 2005	B2
6899684	Mault et al.	May 2005	B2
6902905	Burson et al.	Jun 2005	B2
6904301	Raskas	Jun 2005	B2
6907127	Kravitz et al.	Jun 2005	B1
6915147	Lebel et al.	Jul 2005	B2
6918769	Rink	Jul 2005	B2
6918874	Hatch et al.	Jul 2005	B1
6922578	Eppstein et al.	Jul 2005	B2
6922584	Wang et al.	Jul 2005	B2
RE38775	Kurnik et al.	Aug 2005	E
6923764	Aceti et al.	Aug 2005	B2
6923936	Swanson et al.	Aug 2005	B2
6927246	Noronha et al.	Aug 2005	B2
6931327	Goode, Jr. et al.	Aug 2005	B2
6932084	Estes et al.	Aug 2005	B2
6932894	Mao et al.	Aug 2005	B2
6936006	Sabra	Aug 2005	B2
6936029	Mann et al.	Aug 2005	B2
6940590	Colvin, Jr. et al.	Sep 2005	B2
6941163	Ford et al.	Sep 2005	B2
6946996	Koyama	Sep 2005	B2
6950708	Bowman, IV et al.	Sep 2005	B2
6952603	Gerber et al.	Oct 2005	B2
6954673	Von Arx et al.	Oct 2005	B2
6955650	Mault et al.	Oct 2005	B2
6957102	Silver et al.	Oct 2005	B2
6957107	Rogers et al.	Oct 2005	B2
6958705	Lebel et al.	Oct 2005	B2
6965791	Hitchcock et al.	Nov 2005	B1
6968294	Gutta et al.	Nov 2005	B2
6968375	Brown	Nov 2005	B1
6973706	Say et al.	Dec 2005	B2
6974437	Lebel et al.	Dec 2005	B2
6978182	Mazar et al.	Dec 2005	B2
6979326	Mann et al.	Dec 2005	B2
6990366	Say et al.	Jan 2006	B2
6991096	Gottlieb et al.	Jan 2006	B2
6997907	Safabash et al.	Feb 2006	B2
6997920	Mann et al.	Feb 2006	B2
6998247	Monfre et al.	Feb 2006	B2
6999810	Berner et al.	Feb 2006	B2
7003336	Holker et al.	Feb 2006	B2
7003341	Say et al.	Feb 2006	B2
7004901	Fish	Feb 2006	B2
7005857	Stiene et al.	Feb 2006	B2
7011630	Desai et al.	Mar 2006	B2
7016721	Lee et al.	Mar 2006	B2
7018366	Easter	Mar 2006	B2
7018568	Tierney	Mar 2006	B2
7022072	Fox et al.	Apr 2006	B2
7024236	Ford et al.	Apr 2006	B2
7024245	Lebel et al.	Apr 2006	B2
7025743	Mann et al.	Apr 2006	B2
7029444	Shin et al.	Apr 2006	B2
7039810	Nichols	May 2006	B1
7041468	Drucker et al.	May 2006	B2
7043305	KenKnight et al.	May 2006	B2
7049277	Bragulla et al.	May 2006	B2
7052472	Miller et al.	May 2006	B1
7052483	Wojcik	May 2006	B2
7056302	Douglas	Jun 2006	B2
7070580	Nielsen	Jul 2006	B2
7072718	VonArx et al.	Jul 2006	B2
7072802	Hartlaub	Jul 2006	B2
7074307	Simpson et al.	Jul 2006	B2
7077806	Ackermann et al.	Jul 2006	B2
7081195	Simpson et al.	Jul 2006	B2
7082334	Boute et al.	Jul 2006	B2
7098803	Mann et al.	Aug 2006	B2
7108778	Simpson et al.	Sep 2006	B2
7109878	Mann et al.	Sep 2006	B2
7110803	Shults et al.	Sep 2006	B2
7113821	Sun et al.	Sep 2006	B1
7115884	Walt et al.	Oct 2006	B1
7133710	Acosta et al.	Nov 2006	B2
7134999	Brauker et al.	Nov 2006	B2
7136689	Shults et al.	Nov 2006	B2
7137964	Flaherty	Nov 2006	B2
7150975	Tamada et al.	Dec 2006	B2
7163511	Conn et al.	Jan 2007	B2
7166074	Reghabit et al.	Jan 2007	B2
7171274	Starkweather et al.	Jan 2007	B2
7177690	Woods et al.	Feb 2007	B2
7183068	Burson et al.	Feb 2007	B2
7183102	Monfre et al.	Feb 2007	B2
7187528	Talbot et al.	Mar 2007	B2
7189341	Li et al.	Mar 2007	B2
7190988	Say et al.	Mar 2007	B2
7192450	Brauker et al.	Mar 2007	B2
7198606	Boecker et al.	Apr 2007	B2
7203549	Schommer et al.	Apr 2007	B2
7207974	Safabash et al.	Apr 2007	B2
7226978	Tapsak et al.	Jun 2007	B2
7228163	Ackerman	Jun 2007	B2
7233817	Yen	Jun 2007	B2
7248929	Meadows et al.	Jul 2007	B2
7261691	Asomani	Aug 2007	B1
7267665	Steil et al.	Sep 2007	B2
7276029	Goode, Jr. et al.	Oct 2007	B2
7286894	Grant et al.	Oct 2007	B1
7287031	Karpf et al.	Oct 2007	B1
7295867	Berner et al.	Nov 2007	B2
7297108	Iliff	Nov 2007	B2
7310544	Brister et al.	Dec 2007	B2
7353179	Ott et al.	Apr 2008	B2
7448996	Khanuja et al.	Nov 2008	B2
20010005830	Kuroyanagi	Jun 2001	A1
20010011224	Brown	Aug 2001	A1
20010016310	Brown et al.	Aug 2001	A1
20010016682	Berner et al.	Aug 2001	A1
20010016683	Darrow et al.	Aug 2001	A1
20010020124	Tamada	Sep 2001	A1
20010029340	Mault et al.	Oct 2001	A1
20010032278	Brown et al.	Oct 2001	A1
20010037060	Thompson et al.	Nov 2001	A1
20010037069	Carlson et al.	Nov 2001	A1
20010039504	Linberg et al.	Nov 2001	A1
20010041830	Varalli et al.	Nov 2001	A1
20010044581	Mault	Nov 2001	A1
20010044588	Mault	Nov 2001	A1
20010047125	Quy	Nov 2001	A1
20010049096	Brown	Dec 2001	A1
20010049470	Mault et al.	Dec 2001	A1
20010051787	Haller et al.	Dec 2001	A1
20010056328	Trippel et al.	Dec 2001	A1
20020002326	Causey, III et al.	Jan 2002	A1
20020002328	Tamada	Jan 2002	A1
20020004640	Conn et al.	Jan 2002	A1
20020009810	O'Connor et al.	Jan 2002	A1
20020010414	Coston et al.	Jan 2002	A1
20020016530	Brown	Feb 2002	A1
20020019022	Dunn et al.	Feb 2002	A1
20020019330	Murray et al.	Feb 2002	A1
20020019586	Teller et al.	Feb 2002	A1
20020019748	Brown	Feb 2002	A1
20020022883	Burg	Feb 2002	A1
20020023852	McIvor et al.	Feb 2002	A1
20020026111	Ackerman	Feb 2002	A1
20020026937	Mault	Mar 2002	A1
20020027164	Mault et al.	Mar 2002	A1
20020028995	Mault	Mar 2002	A1
20020040208	Flaherty et al.	Apr 2002	A1
20020042090	Heller et al.	Apr 2002	A1
20020042561	Schulman et al.	Apr 2002	A1
20020045808	Ford et al.	Apr 2002	A1
20020047867	Mault et al.	Apr 2002	A1
20020053637	Conn et al.	May 2002	A1
20020062069	Mault	May 2002	A1
20020063060	Gascoyne et al.	May 2002	A1
20020065453	Lesho et al.	May 2002	A1
20020068858	Braig et al.	Jun 2002	A1
20020068860	Clark, Jr.	Jun 2002	A1
20020072858	Cheng	Jun 2002	A1
20020077765	Mault	Jun 2002	A1
20020077766	Mault	Jun 2002	A1
20020081559	Brown et al.	Jun 2002	A1
20020083461	Hutcheson et al.	Jun 2002	A1
20020087056	Aceti et al.	Jul 2002	A1
20020091312	Berner et al.	Jul 2002	A1
20020099282	Knobbe et al.	Jul 2002	A1
20020099997	Piret	Jul 2002	A1
20020103425	Mault	Aug 2002	A1
20020107433	Mault	Aug 2002	A1
20020107476	Mann et al.	Aug 2002	A1
20020109600	Mault et al.	Aug 2002	A1
20020111547	Knobbe et al.	Aug 2002	A1
20020119711	Van Antwerp et al.	Aug 2002	A1
20020124017	Mault	Sep 2002	A1
20020128594	Das et al.	Sep 2002	A1
20020130042	Moerman et al.	Sep 2002	A1
20020133378	Mault et al.	Sep 2002	A1
20020143241	Thorell	Oct 2002	A1
20020151796	Koulik	Oct 2002	A1
20020151816	Rich et al.	Oct 2002	A1
20020155615	Novikov et al.	Oct 2002	A1
20020161286	Gerber et al.	Oct 2002	A1
20020161288	Shin et al.	Oct 2002	A1
20020177764	Sohrab	Nov 2002	A1
20020182241	Boerenstein et al.	Dec 2002	A1
20020186243	Ellis et al.	Dec 2002	A1
20020188466	Barrette et al.	Dec 2002	A1
20020193885	Legeay et al.	Dec 2002	A1
20020198513	Lebel et al.	Dec 2002	A1
20030004457	Andersson	Jan 2003	A1
20030006669	Pci et al.	Jan 2003	A1
20030023171	Sato et al.	Jan 2003	A1
20030023182	Mault et al.	Jan 2003	A1
20030023317	Brauker et al.	Jan 2003	A1
20030028089	Galley et al.	Feb 2003	A1
20030028120	Mault et al.	Feb 2003	A1
20030032077	Itoh et al.	Feb 2003	A1
20030032867	Crothall et al.	Feb 2003	A1
20030032868	Graskov et al.	Feb 2003	A1
20030032874	Rhodes et al.	Feb 2003	A1
20030040683	Rule et al.	Feb 2003	A1
20030042137	Mao et al.	Mar 2003	A1
20030050537	Wessel	Mar 2003	A1
20030050546	Desai et al.	Mar 2003	A1
20030059631	Al-Lamee	Mar 2003	A1
20030065254	Schulman et al.	Apr 2003	A1
20030065257	Mault et al.	Apr 2003	A1
20030065273	Mault et al.	Apr 2003	A1
20030065274	Mault et al.	Apr 2003	A1
20030065275	Mault et al.	Apr 2003	A1
20030065308	Lebel et al.	Apr 2003	A1
20030076082	Morgan et al.	Apr 2003	A1
20030078481	McIvor et al.	Apr 2003	A1
20030078560	Miller et al.	Apr 2003	A1
20030097082	Purdy et al.	May 2003	A1
20030100040	Bonnecaze et al.	May 2003	A1
20030100821	Heller et al.	May 2003	A1
20030101078	Voegeli et al.	May 2003	A1
20030105407	Pearce et al.	Jun 2003	A1
20030108976	Braig et al.	Jun 2003	A1
20030125612	Fox et al.	Jul 2003	A1
20030125613	Enegren et al.	Jul 2003	A1
20030130616	Steil et al.	Jul 2003	A1
20030134347	Heller et al.	Jul 2003	A1
20030135100	Kim et al.	Jul 2003	A1
20030135333	Aceti et al.	Jul 2003	A1
20030153820	Berner et al.	Aug 2003	A1
20030153821	Berner et al.	Aug 2003	A1
20030158472	Sohrab	Aug 2003	A1
20030158707	Doi	Aug 2003	A1
20030168338	Gao et al.	Sep 2003	A1
20030175806	Rule et al.	Sep 2003	A1
20030176183	Drucker et al.	Sep 2003	A1
20030176933	Lebel et al.	Sep 2003	A1
20030181851	Mann et al.	Sep 2003	A1
20030181852	Mann et al.	Sep 2003	A1
20030187338	Say et al.	Oct 2003	A1
20030187525	Mann et al.	Oct 2003	A1
20030188427	Say et al.	Oct 2003	A1
20030191376	Samuels et al.	Oct 2003	A1
20030191431	Mann et al.	Oct 2003	A1
20030195403	Berner et al.	Oct 2003	A1
20030195462	Mann et al.	Oct 2003	A1
20030199744	Buse et al.	Oct 2003	A1
20030199791	Boecker et al.	Oct 2003	A1
20030199903	Boecker et al.	Oct 2003	A1
20030208110	Mault et al.	Nov 2003	A1
20030208113	Mault et al.	Nov 2003	A1
20030208133	Mault	Nov 2003	A1
20030208409	Mault	Nov 2003	A1
20030211625	Cohan	Nov 2003	A1
20030212346	Yuzhakov et al.	Nov 2003	A1
20030212364	Mann et al.	Nov 2003	A1
20030212379	Bylund et al.	Nov 2003	A1
20030217966	Tapsak et al.	Nov 2003	A1
20030225437	Ferguson	Dec 2003	A1
20030226695	Mault	Dec 2003	A1
20030229514	Brown	Dec 2003	A2
20030232370	Trifiro	Dec 2003	A1
20030235817	Bartkowiak et al.	Dec 2003	A1
20040010207	Flaherly et al.	Jan 2004	A1
20040011671	Shults et al.	Jan 2004	A1
20040015134	Lavi et al.	Jan 2004	A1
20040018486	Dunn et al.	Jan 2004	A1
20040030285	Lavi et al.	Feb 2004	A1
20040030294	Mahurkar	Feb 2004	A1
20040039256	Kawatahara et al.	Feb 2004	A1
20040039406	Jessen	Feb 2004	A1
20040040840	Mao et al.	Mar 2004	A1
20040045879	Shults et al.	Mar 2004	A1
20040054263	Moerman et al.	Mar 2004	A1
20040059201	Ginsberg	Mar 2004	A1
20040068230	Estes et al.	Apr 2004	A1
20040069164	Nakamura et al.	Apr 2004	A1
20040072357	Stiene et al.	Apr 2004	A1
20040073095	Causey, III et al.	Apr 2004	A1
20040074785	Holker	Apr 2004	A1
20040078219	Kaylor	Apr 2004	A1
20040096959	Stiene et al.	May 2004	A1
20040106858	Say et al.	Jun 2004	A1
20040106859	Say et al.	Jun 2004	A1
20040108226	Polychronakos et al.	Jun 2004	A1
20040122353	Shahmirian et al.	Jun 2004	A1
20040122489	Mazar et al.	Jun 2004	A1
20040133164	Funderburk et al.	Jul 2004	A1
20040138588	Saikley et al.	Jul 2004	A1
20040153585	Kawatahara et al.	Aug 2004	A1
20040162035	Petersen et al.	Aug 2004	A1
20040162473	Sohrab	Aug 2004	A1
20040164961	Bal et al.	Aug 2004	A1
20040167383	Kim et al.	Aug 2004	A1
20040167801	Say et al.	Aug 2004	A1
20040171921	Say et al.	Sep 2004	A1
20040172284	Sullivan et al.	Sep 2004	A1
20040176913	Kawatahara et al.	Sep 2004	A1
20040186362	Brauker et al.	Sep 2004	A1
20040186365	Jin et al.	Sep 2004	A1
20040193025	Steil et al.	Sep 2004	A1
20040193090	Lebel et al.	Sep 2004	A1
20040199059	Brauker et al.	Oct 2004	A1
20040202576	Aceti et al.	Oct 2004	A1
20040219664	Heller et al.	Nov 2004	A1
20040225338	Lebel et al.	Nov 2004	A1
20040236200	Say et al.	Nov 2004	A1
20040236251	Roe et al.	Nov 2004	A1
20040248204	Moerman	Dec 2004	A1
20040249250	McGee et al.	Dec 2004	A1
20040249253	Racchini et al.	Dec 2004	A1
20040249254	Racchini et al.	Dec 2004	A1
20040249999	Connolly et al.	Dec 2004	A1
20040253736	Stout et al.	Dec 2004	A1
20040254429	Yang	Dec 2004	A1
20040254433	Bandis et al.	Dec 2004	A1
20040254434	Goodnow et al.	Dec 2004	A1
20040260363	Von Arx et al.	Dec 2004	A1
20040263354	Mann et al.	Dec 2004	A1
20050003470	Nelson et al.	Jan 2005	A1
20050010087	Banet et al.	Jan 2005	A1
20050010269	Lebel et al.	Jan 2005	A1
20050027177	Shin et al.	Feb 2005	A1
20050027179	Berner et al.	Feb 2005	A1
20050027180	Goode, Jr. et al.	Feb 2005	A1
20050027181	Goode, Jr. et al.	Feb 2005	A1
20050027462	Goode, Jr. et al.	Feb 2005	A1
20050027463	Goode, Jr. et al.	Feb 2005	A1
20050031689	Shults et al.	Feb 2005	A1
20050033132	Shults et al.	Feb 2005	A1
20050038680	McMahon	Feb 2005	A1
20050043598	Goode, Jr. et al.	Feb 2005	A1
20050043894	Fernandez	Feb 2005	A1
20050049473	Desai et al.	Mar 2005	A1
20050051427	Brauker et al.	Mar 2005	A1
20050051440	Simpson et al.	Mar 2005	A1
20050054909	Petisce et al.	Mar 2005	A1
20050056552	Simpson et al.	Mar 2005	A1
20050090607	Tapsak et al.	Apr 2005	A1
20050112169	Brauker et al.	May 2005	A1
20050113657	Alarcon et al.	May 2005	A1
20050113658	Jacobson et al.	May 2005	A1
20050118726	Schultz et al.	Jun 2005	A1
20050121322	Say et al.	Jun 2005	A1
20050124873	Shults et al.	Jun 2005	A1
20050131346	Douglas	Jun 2005	A1
20050137471	Haar et al.	Jun 2005	A1
20050143635	Kamath et al.	Jun 2005	A1
20050143636	Zhang et al.	Jun 2005	A1
20050148003	Keith et al.	Jul 2005	A1
20050154271	Rasdal et al.	Jul 2005	A1
20050161346	Simpson et al.	Jul 2005	A1
20050171503	Van Den Berghe et al.	Aug 2005	A1
20050171513	Mann et al.	Aug 2005	A1
20050173245	Feldman et al.	Aug 2005	A1
20050176136	Bird et al.	Aug 2005	A1
20050177036	Shults et al.	Aug 2005	A1
20050181012	Saint et al.	Aug 2005	A1
20050182306	Sloan et al.	Aug 2005	A1
20050182451	Griffin et al.	Aug 2005	A1
20050187720	Goode, Jr. et al.	Aug 2005	A1
20050192557	Brauker et al.	Sep 2005	A1
20050195930	Spital et al.	Sep 2005	A1
20050199494	Say et al.	Sep 2005	A1
20050203360	Brauker et al.	Sep 2005	A1
20050203707	Tsutsui et al.	Sep 2005	A1
20050214892	Kovatchev et al.	Sep 2005	A1
20050215871	Feldman et al.	Sep 2005	A1
20050215872	Berner et al.	Sep 2005	A1
20050239154	Feldman et al.	Oct 2005	A1
20050239156	Drucker et al.	Oct 2005	A1
20050242479	Petisce et al.	Nov 2005	A1
20050245795	Goode, Jr. et al.	Nov 2005	A1
20050245799	Brauker et al.	Nov 2005	A1
20050251083	Carr-Brendel et al.	Nov 2005	A1
20050261563	Zhou et al.	Nov 2005	A1
20050261660	Choi	Nov 2005	A1
20050267780	Ray et al.	Dec 2005	A1
20050271546	Gerber et al.	Dec 2005	A1
20050271547	Gerber et al.	Dec 2005	A1
20050272640	Doyle, III et al.	Dec 2005	A1
20050272985	Kotulla et al.	Dec 2005	A1
20050277164	Drucker et al.	Dec 2005	A1
20050287620	Heller et al.	Dec 2005	A1
20060001538	Kraft et al.	Jan 2006	A1
20060001550	Mann et al.	Jan 2006	A1
20060001551	Kraft et al.	Jan 2006	A1
20060003398	Heller et al.	Jan 2006	A1
20060004271	Peyser et al.	Jan 2006	A1
20060007017	Mann et al.	Jan 2006	A1
20060015020	Neale et al.	Jan 2006	A1
20060015024	Brister et al.	Jan 2006	A1
20060016700	Brister et al.	Jan 2006	A1
20060019327	Brister et al.	Jan 2006	A1
20060020186	Brister et al.	Jan 2006	A1
20060020187	Brister et al.	Jan 2006	A1
20060020188	Kamath et al.	Jan 2006	A1
20060020189	Brister et al.	Jan 2006	A1
20060020190	Kamath et al.	Jan 2006	A1
20060020191	Brister et al.	Jan 2006	A1
20060020192	Brister et al.	Jan 2006	A1
20060025663	Talbot et al.	Feb 2006	A1
20060031094	Cohen et al.	Feb 2006	A1
20060036139	Brister et al.	Feb 2006	A1
20060036140	Brister et al.	Feb 2006	A1
20060036141	Kamath et al.	Feb 2006	A1
20060036142	Brister et al.	Feb 2006	A1
20060036143	Brister et al.	Feb 2006	A1
20060036144	Brister et al.	Feb 2006	A1
20060036145	Brister et al.	Feb 2006	A1
20060036187	Vos et al.	Feb 2006	A1
20060040402	Brauker et al.	Feb 2006	A1
20060052679	Kotulla et al.	Mar 2006	A1
20060058602	Kwiatkowski et al.	Mar 2006	A1
20060063218	Bartowiak et al.	Mar 2006	A1
20060068208	Tapsak et al.	Mar 2006	A1
20060074564	Bartowiak et al.	Apr 2006	A1
20060086624	Tapsak et al.	Apr 2006	A1
20060155180	Brister et al.	Jul 2006	A1
20060173444	Choy et al.	Aug 2006	A1
20060189856	Petisce et al.	Aug 2006	A1
20060189863	Peyser et al.	Aug 2006	A1
20060195029	Shults et al.	Aug 2006	A1
20060198864	Shults et al.	Sep 2006	A1
20060200019	Petisce et al.	Sep 2006	A1
20060200020	Brister et al.	Sep 2006	A1
20060200022	Brauker et al.	Sep 2006	A1
20060211921	Brauker et al.	Sep 2006	A1
20060222566	Brauker et al.	Oct 2006	A1
20060224108	Brauker et al.	Oct 2006	A1
20060235285	Brister et al.	Oct 2006	A1
20060247985	Liamos et al.	Nov 2006	A1
20060248398	Neel et al.	Nov 2006	A1
20060258761	Boock et al.	Nov 2006	A1
20060258929	Goode, Jr. et al.	Nov 2006	A1
20060270922	Brauker et al.	Nov 2006	A1
20060270923	Brauker et al.	Nov 2006	A1
20070016381	Kamath et al.	Jan 2007	A1
20070017805	Hodges et al.	Jan 2007	A1
20070027381	Stafford	Feb 2007	A1
20070027384	Brister et al.	Feb 2007	A1
20070027385	Brister et al.	Feb 2007	A1
20070032706	Kamath et al.	Feb 2007	A1
20070032717	Brister et al.	Feb 2007	A1
20070032718	Shults et al.	Feb 2007	A1
20070045902	Brauker et al.	Mar 2007	A1
20070060814	Stafford	Mar 2007	A1
20070066873	Kamath et al.	Mar 2007	A1
20070078320	Stafford	Apr 2007	A1
20070078321	Mazza et al.	Apr 2007	A1
20070093704	Brister et al.	Apr 2007	A1
20070106135	Sloan et al.	May 2007	A1
20070149873	Say et al.	Jun 2007	A1
20070149874	Say et al.	Jun 2007	A1
20070151869	Heller et al.	Jul 2007	A1
20070161879	Say et al.	Jul 2007	A1
20070161880	Say et al.	Jul 2007	A1
20070163880	Woo et al.	Jul 2007	A1
20070179370	Say et al.	Aug 2007	A1
20070179372	Say et al.	Aug 2007	A1
20070191699	Say et al.	Aug 2007	A1
20070191700	Say et al.	Aug 2007	A1
20070197889	Brister et al.	Aug 2007	A1
20070197890	Boock et al.	Aug 2007	A1
20070203408	Say et al.	Aug 2007	A1
20070203410	Say et al.	Aug 2007	A1
20070203411	Say et al.	Aug 2007	A1
20070203966	Brauker et al.	Aug 2007	A1
20070208247	Say et al.	Sep 2007	A1
20070213610	Say et al.	Sep 2007	A1
20070215491	Heller et al.	Sep 2007	A1
20070218097	Heller et al.	Sep 2007	A1
20070235331	Simpson et al.	Oct 2007	A1
20070244380	Say et al.	Oct 2007	A1
20070249919	Say et al.	Oct 2007	A1
20070249920	Say et al.	Oct 2007	A1
20070249922	Peyser et al.	Oct 2007	A1
20080139910	Mastrototaro et al.	Jun 2008	A1

Foreign Referenced Citations (52)

Number	Date	Country
42 34 533	Jan 1995	DE
100 42 101	Feb 2002	DE
0 504 835	Mar 1992	EP
0 653 718	Nov 1994	EP
0 653 718	Nov 1994	EP
0 800 082	Oct 1997	EP
0 800 082	Oct 1997	EP
0 880 936	Oct 1997	EP
0 970 655	Jan 1998	EP
1 416 417	May 2004	EP
1965691	Sep 2008	EP
1 579 690	Nov 1980	GB
2 194 892	Mar 1988	GB
2 225 637	Jun 1990	GB
10-166894	Jan 2000	JP
10-314029	Apr 2000	JP
WO 8600513	Jan 1986	WO
WO 8706040	Oct 1987	WO
WO 8902246	Mar 1989	WO
WO 9000367	Jan 1990	WO
WO 9506240	Mar 1995	WO
WO 9607908	Mar 1996	WO
WO 9720207	Jun 1997	WO
9724980	Jul 1997	WO
WO 9741421	Nov 1997	WO
WO 9746868	Dec 1997	WO
WO 9809167	Mar 1998	WO
WO 9824366	Jun 1998	WO
WO 9852045	Nov 1998	WO
WO 9905966	Feb 1999	WO
WO 9932883	Jul 1999	WO
WO 0013580	Mar 2000	WO
WO 0020626	Apr 2000	WO
0032258	Jun 2000	WO
WO 0033065	Jun 2000	WO
WO 0049731	Aug 2000	WO
WO 0078210	Dec 2000	WO
WO 0115056	Mar 2001	WO
WO 0124038	Apr 2001	WO
WO 0133216	May 2001	WO
WO 0152727	Jul 2001	WO
WO 0157238	Aug 2001	WO
WO 0157239	Aug 2001	WO
WO 0167009	Sep 2001	WO
WO 0189362	Nov 2001	WO
WO 02056151	Jul 2002	WO
WO 02078512	Oct 2002	WO
WO 02082984	Oct 2002	WO
WO 03017832	Mar 2003	WO
WO 03039361	May 2003	WO
WO 02078512	Jan 2004	WO
WO 02078512	Dec 2004	WO

Non-Patent Literature Citations (118)

Entry
Arnold Henry Kadish, M.D., “Biocybernetics of Bodily Fuels—Monitoring of Blood Glucose and the Establishment of On-Line Metabolic Homeostasis,” Proceedings of the 3.sup.rd Hawaii International Conference on System Sciences Part 1, 1970, pp. 231-234.
Schmalzel, J. L., et al., “An Impedance Pneumograph Utilizing Microprocessor-based Instrumentation,” Proceedings of the Fourteenth Annual Rocky Mountain Bioengineering Symposium, 1977, vol. 13, pp. 63-68.
Walford, S., et al., “Self-Monitoring of Blood Glucose, Improvement of Diabetic Control,” Apr. 8, 1978, The Lancet, pp. 732-735.
Caprihan, A., et al., “A Simple Microcomputer for Biomedical Signal Processing,” IECI '78 Annual Conference Proceedings on Industrial Applications of Microprocessors, Mar. 2-22, 1978, pp. 18-23. R.B. Tattersall, “Home Blood Glucose Monitoring,” Diabetologia, 1979, vol. 16, No. 2, pp. 71-74.
Santigo, J. V., et al., “Closed-loop and Open-loop Devices for Blood Glucose Control in Normal and Diabetic Subjects,” Diabetes, 1979, vol. 28, No. 1, pp. 71-81.
J. Stuart Soeldner, “Treatment of Diabetes Millitus by Devices,” The American Journal of Medicine, Jan. 1981, vol. 70, 183-194.
Stuart J. Updike, et al., “Implanting the Glucose Enzyme Electrode: Problems, Progress, and Alternative Solutions,” Diabetes Care, vol. 5, No. 3, May-Jun. 1982, pp. 207-212.
Kuykendall, V. G., et al., “Assessment of Self-Monitored Blood Glucose Results Using a Reflectance Meter with memory and Microcomputer,” Symposium on Computer Applications in Medical Care, 9th: 1985:Baltimore, M.D., pp. 98-102.
Gifford-Jorgensen, R. A., et al., “Comparison of Five Glucose Meters for Self-Monitoring of Blood Glucose by Diabetic Patients,” Diabetes Care, Jan.-Feb. 1986, vol. 9, No. 1, pp. 70-76.
Lawrence D. Devoe et al., “The Fetal Biophysical Profile: Antepartum Assessment Using a Programmed Microcomputer,” Journal of Clinical Engineering, Jul.-Aug. 1986, vol. 11, No. 4, 285-289.
Chan, K. H., et al., “Microprocessor-Based Cardiopulmonary Rate Monitor,” Medical & Biological Engineering & Computing, Jan. 1987, V. 25, No. 1, pp. 41-44.
Wiesspenier, G., et al, “Cardiotest=Single Chip Cardiac Monitor,” Computer in Cardiology, Sep. 12-15, 1987: Leuven, Belgium (eds.Ripley, R.L.) pp. 463.
Christine A. Beebe, “Self Blood Glucose Monitoring: An Adjunct to Dietary and Insulin Management of the Patient with Diabetes,” Journal of the American Dietetic Association, Jan. 1987, vol. 87, No. 1, pp. 61-65.
Zier, H., et al., “A Miniaturized, Portable Analyser for Operation of Glucose Sensors,” GBF Monographs, 1987, vol. 10, pp. 261-262.
Subramanian,S., et al., “A Medical Device Data Acquisition System Using a Microcomputer-Based Software Interface,” IEEE Engineering in Medicine and Biology Society 10.sup.th Annual International Conference, 1988, pp. 1432-1433.
“Central Fetal Monitoring Systems with Optical Disk Storage,” Health Technology, 1988, vol. 2, pp. 249-251.
“Paying Attention to the ‘Constants’ in the Medical Care Equation,” Health Technology, vol. 2, pp. 252-257.
Blood Glucose Monitors, Portable, Health Device, V. 17(9), 253-271 (1988).
Douglas, A.S., et al., “Hand-Held Glucose Monitor and Recorder,” Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, New Orleans, Nov. 4-7, 1988, pp. 747-748.
Stuart J. Updike, et al, “Laboratory Evaluation of New Reusable Blood Glucose Sensor,” Diabetes Care, Nov./Dec. 1988, vol. 11, No. 10, pp. 801-807.
“Meters for Glucose Monitoring,” The Medical letter on Drugs and Therapeutics, 1988, vol. 30, No. 778, pp. 101-102.
Beverly J. Leyerle, et al., “The PDMS as a Focal Point for Distributed Patient Data,” International Journal of Clinical Monitoring and Computing, 1988, vol. 5, pp. 155-161.
“Blood Glucose Monitors,” Health Devices, Sep. 1988, vol. 17, No. 9, pp. 253-271.
Daisuke Yoshizawa, et al., “The Development of a Data processing System with Personal Computer of MSX Standard System for Flow Injection Analysis,” Journal of Flow Injection Analysis, 1988, V. 5, No. 2, pp. 101-110.
Zier, H., et al., “Portable Glucose Measurement in Blood,” Artificial Organs, 1989, vol. 13, No. 2, pp. 176.
Zviran, M., et al., “DMSS—A Computer-Based Diabetes Monitoring System,” Journal of Medical Systems, 1989, vol. 13, No. 5, pp. 293-308.
A.C. Thai, “Portable Meters for Self-Monitoring of Blood Glucose,” Annals Academy of Medicine, Jul. 1989, vol. 18, No. 4, pp. 444-452.
A. Michael Albisser, “Intelligent Instrumentation in Diabetic Management,” CRC CRitical Reviews in Biomedical Engineering, 1989, vol. 17, Issue 1, pp. 1-24.
“New Computer Uses Can Improve Diabetics' Lot,” The Australian Journal of Pharmacy, Feb. 1989, vol. 70, pp. 144, 146-147.
J. Schrezenmeir, et al., “Computer Assisted Insulin Dosage Adjustment-Perspectives for Diabetes Control,” Hormone and Metabolic Research, Supplement Series 1990, vol. No. 24, pp. 116-123.
Phillipou, G., et al., “Computer Based Quality Assessment of Hospital Capillary Blood Glucose Monnitoring,” Diabetic Medicine, 1990, vol. 7, No. 3, pp. 234-237.
Cumbee, S. R., et al., “Cardiac Loop ECG Rcording: A New Noninvasive Diagnostic Test in Recurrent Syncope,” Southern Medical Journal, 1990, vol. 83, No. 1, 39-43.
N. Ito, et al, “A Novel Blood Glucose Monitoring System Based on an ISFET Biosensor and its Application to a Human 75 g Oral Glucose Tolerance Test,” Sensors and Actuators, B1, 1990, vol. 81(1-6) pp. 488-490.
E.F. Pfeiffer, “The Glucose Sensor: The Missing Link in Diabetes Therapy,” Hormone and Metabolic Research, 1990, vol. 24, Suppl., pp. 154-164.
Laughton E. Miles, “A Portable Microcomputer for Long-Term Physiological Monitoring in the Home and Work Environment,” Medical Monitoring in the Home and Work Environment, 1990, pp. 47-57.
Zamzow, K. et al., New Wearable Continuous Blood Glucose Monitor (BGM) and Artificial Pancreas (AP), Diabetes, 39:5A(20) (May 1990).
Carl E. Speicher, “The Bottom Line, Can Portable Blood Glucose Monitoring Improve the Outcomes of Diabetic Patients?,” American Journal of Clinical Pathology, Feb. 1991, vol. 95, No. 2, pp. 112-116.
Kaj Lindecrantz, et al., “A System for Acquisition and Storage of Intra Partum Fetal ECG,” Journal of Perinatal Medicine, vol. 19, Suppl. 1, pp. 342-345.
Kahn, M. G., et al., “Intelligent Computer-Based Interpretation and Graphical Presentation of Self-Monitored Blood Glucose and Insuling Data,” Diab. Nurt. Meta., 1991, vol. 4, Suppl. 1, pp. 99-107.
Latman, N. S., “Evaluation of Electronic, Digital Blood Glucose Monitors,” Biomedical Instrumentation and Technology, 1991, vol. 25, No. 1, 43-49.
Reinauer, K. M., et al., “Evaluation of Systems for Computer-Assited Glucose-Reflectance Meters and Comparison of their Software,” Diab. Nutr. Metab., 1991, vol. 4, Suppl. 1, pp. 109-115.
Dino A. Vallera, M.D., et al., “Accuracy of Portable Blood Glucose Monitoring, Effect of Glucose Level and Prandial State,” Clinical Chemistry, A.J.C.P., Feb. 1991, pp. 247-252.
Schvarcz, E., et al., “Incidence of Symptomatic Mild Hypoglycemic Events: A Prospective Study in Adult Patients with Insulin-Treated Diabetes Mellitus Using a Portable Microcomputer-Based Data Logger,” Diabetes Research, 1991, vol. 16, pp. 25-28.
M.F. Burritt, et al, “Portable Blood Glucose Meters: Teaching Patients How to Correctly Monitor Diabetes,” Postgraduate Medicine, Mar. 1991, vol. 89, No. 4, pp. 75-78, 81, 84.
P.G. Fabietti, et al., “Wearable System for Acquisition, Processing and Storage of the Signal from Amperometric Glucose Sensors”, International Journal of Artificial Organs, 1991, vol. 14, No. 3, pp. 175-178.
Raj Ajit K. Srivastava, “Effect of Glycosylation of Bacterial Amylase on Stability and active Site Conformation,” Indian Journal of Biochemistry & Biophysics, Apr. 1991, vol. 28, No. 2, pp. 109-113.
Chen, C.Y. et al., “A Biocompatible Needle-Type Glucose Sensor Based on Platinum-Electroplated Carbon Electrode”, Applied Biochemistry and Biotechnology, 36:211-226 (1992).
Andre J. Scheen, “Devices for the Treatment of Diabetes: Today,” Artificial Organs, 1992, vol. 16, No. 2, pp. 13-166.
Charles L. Bryan, M.D., et al., “Ways to Improve Outcome After Cardiopulmonary Resuscitation, How to Monitor Patients, Correct Dysrhythmias,” The Journal of Critical Illness, Aug. 1992, vol. 7, No. 8, pp. 1330-1347.
Thomas Hauser, et al., “Will Computers Replace or Complement the Diabetes Educator?,” The Medical Journal of Australia, Oct. 5, 1992, vol. 157, 489-491.
Phillipou, G., et al., “Capillary Blood Glucose Measurements in Hospital Inpatients Using Portable Glucose Meters,” Australian and new Zealand Journal of Medicine, 1993, vol. 23, No. 6, pp. 667-671.
Poitout, V., et al., “A Glucose Monitoring System for on Line Estimation in Man of Blood Glucose Concentration Using a Miniaturized Glucose Sensor Implanted in the Subcutaneous Tissue and a Wearable Control Unit,” Diabetologia, 1993, vol. 36, No. 7, pp. 658-663.
Esch Hogen, et al., “Methods and Applications of Radio Identification” Tiidschirft van het Nederlands Electronica—en Radiogenootschap, 1993, vol. 58, No. 1, pp. 9-12.
V. L. Rose, et al., “Decentralized Testing for Prothrombin Time and Activated Partial Thromboplastin Time Using a Dry Chemistry Portable Analyser,” Archives of Pathology and Laboratory Medicine, Jun. 1993, vol. 117, pp. 611-617.
Tsunenori Arai, et al., “A Portable Transcutaneous Blood Glucose Monitoring System Using Non-Invasive Collection of Suction Effusion Fluid From Skin,” Proceedings of the 16.sup.th Annual International Conference of the IEEE Engineering in Medicine and Biology Socienty, Engineering Advances: New Opportunities for Biomedical Engineers, Jun. 1994, vol. 2, 812-813.
Hiroyuki Horio, et al., “Clinical Telecommunication Network System for Home Monitoring”, Medical & Biological Engineering & Computing., Mar. 1994, vol. 32, 227-230.
Makikawa, M., et al., “Microprocessor-Based Memory Device for Ambulatory Heart Rate and Physical Activity Recording,” Methods of Information in Medicine, 1994, vol. 33,, No. 1, pp. 94-96.
Marc C. Shults, et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors,” IEEE Transactions on Biomedical Engineering, Oct. 1994, vol. 41, No. 10, pp. 937-942.
David Potter, “Fundametals of PC-Based Data Acquisition,” SENSORS, Feb. 1994, pp. 12-20.
Skrabal, F., et al., “Portable System for On-Line Continuous Ex Vivo Monitoring of Subcutaneous Tissue Glucose Using Open Tissue Perfusion,” Medical & Biological Engineering and Computing, Jan. 1995, vol. 33, No. 1, pp. 116-118.
James H. Nichols, et al., “Laboratory and Bedside Evaluation of Portable Glucose Meters,” American Journal of Clinical Pathology, Feb. 1995, vol. 103, No. 2, pp. 244-251.
J. P. Kassirer, “The Next Transformation in the Delivery of Health Care,” The New England Journal of Medicine, Jan. 5, 1995, vol. 332, No. 1, pp. 52-54.
V. Netz, Using Chip Cards to Promote Personal Health, Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 256-260.
K. Hara, “Application of Optical Memory Card for the Management of Maternity Care,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 276-278.
R. Beyer, “Smart Cards, Technololgies and their Application,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 145-149.
M. Michael Shabot, et al., “Real-Time-Wireless Decision Support Alerts on a Palmtop PDA,” 19th Annual Symposium on Computer Applications in Medical Care. Toward Cost-Effective Clinical Computing, Oct.-Nov. 1995, pp. 174-177.
German language document: Sensor '95: “Neuheiten und Trends in der Sensorik,” (Sensors '95: New Development and Trends in the Sensor Development, Sensors Report, May 1995, vol. 10, No. 3, pp. 14-18.
Michael E. Moseley, Ph.D., “MRI—Mapping the Human Brain Electronically”, WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 656-659.
Table of Contents, Wescon '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995.
Table of Contents of Health Cards '95 Conference, Oct. 23-26, 1995.
Cor J. Kalkman, “LabVIEW: A software System for Data Acquisition, Data Analysis, and Instrument Control,” Journal of Clinical Monitoring, Jan. 1995, vol. 11, No. 1, pp. 51-58.
Eberhard Brunner, “An Ultra-low Noise Linear-in-DB Variable Gain Amplifier for Medical Ultrasound Applications,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 650-655.
Willis G. Downing, Jr., “Electronic Measurements of Pulmonary Mechanics,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 644-649.
Lisa E. Hake, “An Eye on the Future: Advances in Eye Care Technology,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 638.
Stephen Harper, “Update on PCMCIA Standard Activities: CardBus and Beyond,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 135-164.
V. Manfrini, et al., “Dual Concentric Conductor Arrays for Microwave Hyperthermia: Theoretical Study of Design Parameters,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 661-684.
Charles Melear, “Configurable Modules of the MC68300 and MC68HC16 Microcontroller Families,” WESCON '95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 44-50.
G. Schlegelmilch, “Contributions of an IC-Manufacturer to Chip Card—Projects in Health Service Applications,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 327-330.
A. F. Brockman, et al., “The Use of the Optical Memory Card to Facilitate Patient Centered Care During Pregnancy and to Provide a Basis for an Integrated Perinatal Data Collection System,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 197-201.
K. Hirayama, et al., “Optical Memory Card—Present and Future State of the Technology and its Applications,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 321-326.
P. Wenzlaff, et al., “DEFICARD: Health Card Project in Cardiology. Concept and One-Year-Report on Field Trial Experiences,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 222-224.
H. Hrabcik, et al., Medical Functions on a Dynamically Multifunctional Personal Chip System (mPCS), Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 240-242.
M. Kossmann, “Experiences with the X-Ray Card,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 243-245.
M. Opiela, “Multi-Functional Cards for Health Care Applications,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 288-290.
K. Ozasa, et al., “Health Administration System Using an Optical Memory Card in a Rural Community,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 279-283.
J. Berube, et al., “The Evaluation of the Rimouski Project: A Strategy for Development,” Proceedings of the Health Cards '95 Conference, Oct. 1995, pp. 169-170.
John T. Oldenburg, “A Virtual Instrument Design Laboratory for Rapid Prototyping of Medical Instrumentation,” WESCON 95: Conference Record, San Francisco, CA, Nov. 7-9, 1995, pp. 639-643.
Motorola Product Brief: MPC860ADS—Application Development System, 1995, pp. 4.
Motorola Product Brief MD68302 Family Application Development System, 1995, 4 pages.
Motorola Product Brief MPC821ADS—Application Development Sysytem, 1995, 4 pages, Rev. 1.1.
Report by Tom Balph, EC020/683XX Interface to ISA Bus-type PCMCIA Controller, 11 pages, Mar. 9, 1995.
Motorola MPC860 On-Chip Access Guide, MPC860 User's Manual, pp. 909-928.
Motorola MC68LC302 product Brief, Low Cost Intergrated Multiprotocol Processor, 1995, 6 pages.
A. M. Albisser, et al., “Diabetes Intervation in the Information Age,” Medical Informatics, 1996, vol. 21, No. 4, pp. 297-316.
German Language Article: Aufgaben der Multisensorik, Design & Electronik vol. 39, No. 20, 1996, pp. 49.
Michael Greger, “PC-Cards die Vielfalt wachst” Electronik, Oct. 1996, vol. 45, No. 15, pp. 56-59.
C. Karen Altieri, “Introduction of a Fully Portable, Body-Mounted Emergency Medical Information System,” Proceedings of the National Forum: Military Telemedicine On-Line Today Research, Practice, and Opportunities, 1996, pp. 135-140.
Rolf Engelbrecht, et al., “DIABCARD—A Smart Card for Patients with Chronic Diseases,” Clinical Performance and Quality Healthcare, Apr./May/Jun. 1997, No. 5, vol. 2, pp. 67-70.
S. F. Kurikov, et al., “Use of a Sigma-Delta Analog-to-Digital Converter in Multichannel Electrocardiographs,” Biomedical Engineering, 1997, vol. 31, No. 4, pp. 190-194.
Steven M. George, “NTIS: Computer Aided Medical Assistant (CAMA) System,” NTIS: Report No. ARO-36050.1-MA-STI, Mar. 11, 1997, pp. 1-24.
MC68PM302 Device Errata, Revision C Changes, Feb. 27, 1997, 2 pages. Motorola Introduction to EBX, Version 1.8, Apr. 2, 1997, 2 pages.
A. Pizzuti, et al., “Valutazione di una scheda per la registrazione e l'archiviazione di electtrocardiogrammi con personal computer non dedicato,” Minerva Cardioangiologia, V. 45, No. 7-8, 1997, pp. 357-361; English Abstract included: Evaluation of an Electrocardiographic Card to be directly Inserted into a Standard Personal Computer.
User's Guide, Accu-Chek Compass Diabetes Care Software, Roche Diagnostics, pp. 1-93 (2000).
Internet printout: MC68302 Product Summary Page, printed Nov. 8, 2002, www.motorola.com, 6 pages.
Motorola Report on Science, Standards and Stewardship, Wireless Safety Update, Sep. 2002, 11 pages.
Internet printout: Motorola Announces Latest Developer's Kits for Its Pagewriter 2000 Two-Way Pager, Pagewriter 2000X Two-Way Wireless Communications Center and Creatalink 2XT Two-Way Data Transceiver, www.motorola.com, 2 pages.
Internet printout: MC68356: Signal Processing Communication Engine (SPCE), www.motorola.com, printed Nov. 8, 2002, 2 pages.
PCMCIA Release 2.0 Interface Board for Dragonball Update, www.motorola.com, Nov. 24, 1998, 5 pages.
Internet printout: A Complete Control and Monitoring Solution—Motorola's Creatalink 2 XT Two-Way Data Transceiver Can Provide Wireless Communications Between Devices and People, www.motorola.com, printed Nov. 8, 2002, 2 pages.
Internet printout: QRS Products, Software Integration, Office Medic IDMS, Spirometry, Press Release, (QRS Diagnostic Secures International Approvals on key Patent; Sunrise Lifestyle Centers Selects QRS Medical Devices; QRS and CompleWare Integrate Software and Medical Devices to Streamline Data Collection and Management for Clinical Trials; Physicians Worldwide Can Now Use Advanced patient Information management Software and Medical Devices from QRS Diagnostic; QRS Releases Office Medic Small Office Edition Software), QRS Diagnostic, printed Oct. 31, 2002, 17 pages.
Internet printout: Voyager Pulse Oximeter, www.dolphinmedical.com, Oct. 31, 2002, 3 pages.
Internet printout: Accu-Chek Pocket Compass, 6 pages.
Internet printout: Accu-Chek Compass, Accu-Chek Pocket Compass, www.accu-chek.com, printed on Oct. 12, 2002, 17 pages.
Internet printout: How Flash Memory Works, CompactFlash, by Jeff Tyson, www.howstuffworks.com, printed on Sep. 28, 2002, 2 pages.
Internet printout: How Flash Memory Works, SmartMedia, by Jeff Tyson, www.howstuffworks.com, printed on Sep. 28, 2002, 2 pages.
Internet printout: How Flash Memory Works, Gadget of the Day, by Marshall Brain, www.howstuffworks.com, printed on Sep. 28, 2002, 2 pages.
Internet printout: Fingerprint ID, Biometric Logon, Data Access Protection and Fingerprint ID, www.motorola.com and www.guardwaresystems.com, 16 pages, printed on Nov. 8, 2002.
Smale et al., (IEE Colloquium on Intelligent Instrumentation, p. 5-7, May 13, 1991).

Related Publications (1)

	Number	Date	Country
	20110038765 A1	Feb 2011	US

Provisional Applications (2)

	Number	Date	Country
	60300011	Jun 2001	US
	60280905	Apr 2001	US

Continuations (2)

	Number	Date	Country
Parent	11160407	Jun 2005	US
Child	12913559		US
Parent	10112671	Mar 2002	US
Child	11160407		US

Blood glucose tracking apparatus

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract